UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 
SCHEDULE 14A
 
(RULE 14a-101)
SCHEDULE 14A INFORMATION
 
Proxy Statement Pursuant to Section 14(a) of
the Securities Exchange Act of 1934 (Amendment No.     )

Filed by the Registrant     þ
Filed by a Party other than the Registrant     o
Check the appropriate box:
o	Preliminary Proxy Statement	
o	Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))	
þ	Definitive Proxy Statement	
o	Definitive Additional Materials	
o	Soliciting Material Pursuant to 240.14a-12	
 
Chemed Corporation	
(Name of Registrant as Specified In Its Charter)	
 
(Name of Person(s) Filing Proxy Statement, if other than the Registrant)
 
Payment of Filing Fee (Check the appropriate box):
þ	No fee required.	
o	Fee computed on table below per Exchange Act Rules 14a-6(i)(1) and 0-11.	
 
 	(1)	Title of each class of securities to which transaction applies:	

 	 	 	
 	(2)	Aggregate number of securities to which transaction applies:	

 	 	 	
 	(3)	Per unit price or other underlying value of transaction computed pursuant to Exchange Act Rule 0-11 (set forth the amount on which the filing fee is calculated and state how it was determined):	

 	 	 	
 	(4)	Proposed maximum aggregate value of transaction:	

 	 	 	
 	(5)	Total fee paid:	

 

 
 
o	Fee paid previously with preliminary materials.	
o	Check box if any part of the fee is offset as provided by Exchange Act Rule 0-11(a)(2) and identify the filing for which the offsetting fee was paid previously. Identify the previous filing by registration statement number, or the Form or Schedule and the date of its filing.	
 
 	(1)	Amount Previously Paid:	

 	 	 	
 	(2)	Form, Schedule or Registration Statement No.:	

 	 	 	
 	(3)	Filing Party:	

 	 	 	
 	(4)	Date Filed:	

 

 

 
NOTICE OF ANNUAL MEETING OF STOCKHOLDERS
MAY 20, 2013
 
The Annual Meeting of Stockholders of Chemed Corporation will be held at The Queen City Club, 331 East Fourth Street, Cincinnati, Ohio, on May 20, 2013, at 11:00 a.m. Eastern Time for the following purposes:
 
(1)	To elect directors;	
 
(2)	To ratify the selection of independent accountants by the Audit Committee of the Board of Directors;	
 
(3)	To hold an advisory vote to approve executive compensation; and	
 
(4)	To transact any other business properly brought before the meeting.	
 
The above matters are described in the Proxy Statement accompanying this Notice.  You are urged, after reading the Proxy Statement, to vote your shares by proxy using one of the following methods:  (a) complete, sign, date and return your proxy card in the postage-paid envelope provided, or (b) vote by telephone or vote via the Internet using the instructions on your proxy card.  Voting instructions are described in more detail in the Proxy Statement.

Your vote is extremely important.  If you have any questions or require any assistance with voting your shares, please contact the Company’s transfer agent:

Wells Fargo Shareowner Services
1-800-468-9716

Stockholders of record at the close of business on March 28, 2013, are entitled to notice of, and to vote at, the Annual Meeting.

 	Naomi C. Dallob	
 	Secretary	
 
April 5, 2013

 

 

Table of Contents	 	
 	PAGE	
CONSIDERATION OF 2012 SAY ON PAY VOTE	1	
 	
2012 COMPENSATION	1	
 	
2012 PERFORMANCE	1	
 	
PROXY STATEMENT	4	
Purpose	4	
Voting Instructions	4	
Vote Requirements	5	
 	
PROPOSAL 1 – ELECTION OF DIRECTORS	6	
General	6	
Nominees	7	
Recommendation	9	
 	
DIRECTOR COMPENSATION	9	
Narrative Disclosure to Director Compensation Table	9	
Directors Emeriti	10	
 	
MAJORITY VOTING IN DIRECTOR ELECTIONS	10	
 	
CORPORATE GOVERNANCE	11	
Board of Directors Meetings and Committees	11	
Procedures Regarding Director Candidates Recommended by Stockholders	11	
Director Independence	12	
Board Risk Oversight	12	
Compensation Committee Interlocks and Insider Participation	13	
Compensation Risk	13	
Board Leadership Structure	13	
Code of Ethics	13	
Stockholder Communication	14	
 	
COMPENSATION DISCUSSION AND ANALYSIS	14	
Executive Summary	14	
Discussion of Our Overall Compensation Philosophy and Objectives	15	
Role of the Committee, Management and Compensation Consultants	15	
Executive Officers	15	
Executive Compensation Consultant, Independence	16	
Peer Groups	17	
Elements of Executive Compensation	17	
Base Salaries	17	
Annual Incentive Incentives	18	
Long-Term Incentives	20	
Retirement Benefits	21	
Employment Agreements	22	
Tax Considerations	22	
Stock Ownership Guidelines	23	

 

 

REPORT OF THE COMPENSATION COMMITTEE	24	
 	
EXECUTIVE COMPENSATION	25	
Summary Compensation	25	
All Other Compensation Tables	26	
Grants of Plan-Based Awards	27	
Narrative Disclosure to Summary Compensation Table and Grants of Plan-Based Awards Table	27	
Employment Agreements	28	
Annual Cash Incentives	29	
Stock Incentive Plans	29	
Long-Term Incentive Plan	29	
Outstanding Equity Awards at Fiscal Year End	30	
Option Exercises and Stock Vested	32	
Nonqualified Deferred Compensation	32	
Excess Benefit Plan and Deferred Compensation Plan	33	
Potential Payments Upon Termination or Change of Control	34	
 	
TRANSACTIONS WITH RELATED PERSONS	40	
Transactions with Related Persons	40	
 	
SECURITY OWNERSHIP	41	
Security Ownership of Certain Beneficial Owners	41	
Security Ownership of Executive Officers and Directors	42	
 	
ANTI-HEDGING POLICY	43	
 	
SECTION 16(A) BENEFICIAL OWNERSHIP REPORTING COMPLIANCE	43	
 	
PROPOSAL 2 - RATIFICATION OF APPOINTMENT OF INDEPENDENT REGISTERED	 	
PUBLIC ACCOUNTING FIRM	43	
Recommendation	43	
 	
REPORT OF THE AUDIT COMMITTEE	43	
 	
PRINCIPAL ACCOUNTANT FEES AND SERVICES	44	
 	
PROPOSAL 3 – ADVISORY VOTE ON EXECUTIVE COMPENSATION	45	
Our Compensation Philosophy and Practices	45	
Effect of Say on Pay Vote	46	
Recommendation	46	
 	
PROPOSALS FOR THE NEXT ANNUAL MEETING	46	
Proposals to be Included in Our 2014 Proxy Statement	46	
Stockholder Proposals Regarding Nominations or Other Business at the 2014 Annual Meeting	46	
 	
IMPORTANT NOTICE REGARDING AVAILABILITY OF	 	
PROXY MATERIALS FOR ANNUAL MEETING	46	
 	
OTHER INFORMATION	47	

 

 
 
Consideration of the 2012 Say On Pay Vote
 
Following our 2012 annual meeting of stockholders, the Compensation Committee and the Board of Directors reviewed the results of the non-binding stockholder advisory vote on our executive compensation (“2012 Say On Pay Vote”).  Stockholders voted against Say On Pay, with 51.9% negative votes and 47.7% positive votes.  We believe this negative vote was caused in part by a short-term decline in our stock price beginning in mid-November 2011 that ended in mid-January 2012.  Based on input solicited from stockholders in connection with this vote, as well as our ongoing dialogue with our stockholders, the Compensation Committee and Board adopted significant changes to our executive compensation policies and practices as follows (abbreviated terms are defined within):
 
·  	Changed the timing of the award of stock options from February, the time at which prior year annual incentive compensation is paid, to November of each year.  This will allow the Compensation Committee to take into consideration a greater degree of current year performance in aligning compensation with performance;	
 
·  	Considered the relative impact of awarding stock options as compared to stock awards;	
 
·  	Eliminated the discretionary pool of shares of Capital Stock which the Compensation Committee could award to LTIP recipients upon achievement of either the EBITDA or stock price targets under that plan;	
 
·  	Predetermined amounts to be awarded to the named executive officers pursuant to the LTIP should EBITDA or stock price targets be attained, rather than allocating at the time of attainment;	
 
·  	Eliminated the Compensation Committee’s discretion to adjust the amounts paid in annual incentive compensation under the formula of “two times the rate of growth or decline in adjusted earnings per share minus 10%” (“Adjusted EPS” is defined under “Annual Incentive Compensation”).  The Compensation Committee now uses that strict formula, with no discretion, in calculating annual cash incentives for the named executive officers; and	
 
·  	Revised the CD&A presentation in response to the 2012 Say On Pay Vote and in response to comments solicited from stockholders.	
 
Management solicited feedback in connection with this vote from stockholders representing ownership of more than 60% of the total shares outstanding.

2012 Compensation

The Board believes that our executive compensation program provides our executive officers with a balanced compensation package that includes a reasonable base salary along with annual and long-term incentive compensation plans that are based on the Company’s financial performance.  For 2012, about 73 percent of our President and Chief Executive Officer’s actual total direct compensation was performance-based, while the average for the other named executive officers was about 64 percent.  “Performance-based” compensation includes non-equity incentive awards, option awards, and equity incentive and market-based stock awards.

2012 Performance
 
The following chart summarizes both Chemed’s Adjusted EPS and stock price performance since 2003.

1

 

 
(1) Adjusted Diluted EPS; see Appendix on the following page for the reconciliation from GAAP reported results to adjusted (non-GAAP) results (2) Adjusted for stock splits EPS and Stock Price History (1) (2) Adj. Diluted EPS Adj. Stock Price Chemed has delivered strong and consistent EPS to stockholders since 2003, 33.2% 9-year CAGR Adj. Diluted EPS Adj. Stock Price 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2 $80 $75 $70 $65 $60 $55 $50 $45 $40 $35 $30 $25 $20 $5.50 $5.25 $5.00 $4.75 $4.25 $4.00 $3.75 $3.25 $3.00 $2.75 $2.25 $2.00 $1.75 $1.50 $1.25 $1.00 $0.75 $0.50 $0.25

2

 
 
 CHEMED CORPORATION
 RECONCILIATION OF ADJUSTED EBITDA and ADJUSTED NET INCOME
FOR THE YEARS ENDED DECEMBER 31, 2003 THROUGH 2012
 
(IN THOUSANDS)
 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	
 	 	 	 	 	(1)	 	 	 	(2)	 	 	 	(3)	 	 	 	(4)	 	 	 	(5)	 	 	 	(6)	 	 	 	(7)	 	 	 	(8)	 	 	 	(9)	 	 	 	(10)	 	
 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	
 	 	 	 	 	 2003	 	 	 	 2004	 	 	 	 2005	 	 	 	 2006	 	 	 	 2007	 	 	 	 2008	 	 	 	2009	 	 	 	2010	 	 	 	2011	 	 	 	2012	 	
Reconciliation of Adjusted EBITDA	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	
 	      (1)	 	 Net income/(loss)	$ 	     (3,435	) 	 	$	 27,512	 	 	$ 	     35,817	 	 	$ 	 50,651	 	 	$ 	  61,641	 	 	$ 	   67,281	 	 	$	  73,784	 	 	$	 81,831	 	 	$	85,979	 	 	$	   89,304	 	
 	      (2)	 	 Discontinued operations	 	       14,623	 	 	 	       (8,417	) 	 	 	            411	 	 	 	           7,071	 	 	 	         (1,201	)	 	 	           1,088	 	 	 	              253	 	 	 	                -	 	 	 	                -	 	 	 	                -	 	
 	      (3)	 	 Interest expense	 	         3,177	 	 	 	       21,158	 	 	 	       21,264	 	 	 	         17,468	 	 	 	         14,921	 	 	 	         12,123	 	 	 	         11,599	 	 	 	       11,959	 	 	 	       13,888	 	 	 	       14,723	 	
 	      (4)	 	 Income taxes	 	         6,180	 	 	 	       13,736	 	 	 	       18,428	 	 	 	         32,562	 	 	 	         37,721	 	 	 	         47,035	 	 	 	         46,583	 	 	 	       52,000	 	 	 	       54,577	 	 	 	       56,515	 	
 	      (5)	 	 Depreciation	 	         9,519	 	 	 	       14,542	 	 	 	       16,150	 	 	 	         16,775	 	 	 	         20,118	 	 	 	         21,581	 	 	 	         21,535	 	 	 	       24,386	 	 	 	       25,247	 	 	 	       26,009	 	
 	      (6)	 	 Amortization	 	            302	 	 	 	         3,779	 	 	 	         4,922	 	 	 	           5,255	 	 	 	           5,270	 	 	 	           5,924	 	 	 	           6,367	 	 	 	         4,657	 	 	 	         4,252	 	 	 	         4,512	 	
 	      (7)	 	 EBITDA	 	       30,366	 	 	 	       72,310	 	 	 	       96,992	 	 	 	       129,782	 	 	 	       138,470	 	 	 	       155,032	 	 	 	       160,121	 	 	 	     174,833	 	 	 	     183,943	 	 	 	     191,063	 	
 	 	 	  Add/(deduct)	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	
 	      (8)	 	 (Gains)/losses on investments	 	       (5,390	) 	 	 	                -	 	 	 	                -	 	 	 	           1,445	 	 	 	                  -	 	 	 	                  -	 	 	 	         (1,211	) 	 	 	                -	 	 	 	                -	 	 	 	                -	 	
 	      (9)	 	 Gain on sale of property	 	                -	 	 	 	                -	 	 	 	                -	 	 	 	                  -	 	 	 	         (1,138	) 	 	 	                  -	 	 	 	                  -	 	 	 	                -	 	 	 	                -	 	 	 	                -	 	
 	    (10)	 	 Impairment loss on transportation equipment                 	 	 -	 	 	 	                -	 	 	 	                -	 	 	 	                  -	 	 	 	                  -	 	 	 	           2,699	 	 	 	                  -	 	 	 	                -	 	 	 	                -	 	 	 	                -	 	
 	    (11)	 	 Severance charges	 	         3,627	 	 	 	                -	 	 	 	                -	 	 	 	                  -	 	 	 	                  -	 	 	 	                  -	 	 	 	                  -	 	 	 	                -	 	 	 	                -	 	 	 	                -	 	
 	    (12)	 	 Interest income	 	       (1,860	) 	 	 	       (1,874	) 	 	 	       (2,198	) 	 	 	         (2,691	) 	 	 	         (3,304	) 	 	 	            (743	) 	 	 	            (423	) 	 	 	          (444	) 	 	 	          (426	) 	 	 	          (809	) 	
 	    (13)	 	 Dividend income from VITAS	 	       (1,532	) 	 	 	                -	 	 	 	                -	 	 	 	                  -	 	 	 	                  -	 	 	 	                  -	 	 	 	                  -	 	 	 	                -	 	 	 	                -	 	 	 	                -	 	
 	    (14)	 	 Equity in earnings of VITAS	 	          (922	) 	 	 	         4,105	 	 	 	                -	 	 	 	                  -	 	 	 	                  -	 	 	 	                  -	 	 	 	                  -	 	 	 	                -	 	 	 	                -	 	 	 	                -	 	
 	    (15)	 	 Advertising cost adjustment	 	            829	 	 	 	            528	 	 	 	            691	 	 	 	              323	 	 	 	              601	 	 	 	              225	 	 	 	            (540	) 	 	 	          (679	) 	 	 	       (1,240	) 	 	 	       (1,573	) 	
 	    (16)	 	 Long-term incentive compensation	 	                -	 	 	 	         8,783	 	 	 	         5,477	 	 	 	                  -	 	 	 	           7,067	 	 	 	                  -	 	 	 	           5,007	 	 	 	         4,734	 	 	 	         3,012	 	 	 	            360	 	
 	    (17)	 	 Loss/(gain) on extinguishment of debt	 	                -	 	 	 	         3,330	 	 	 	         3,971	 	 	 	              430	 	 	 	         13,798	 	 	 	         (3,406	) 	 	 	                  -	 	 	 	                -	 	 	 	                -	 	 	 	                -	 	
 	    (18)	 	 Legal expenses of OIG investigation	 	                -	 	 	 	                -	 	 	 	            637	 	 	 	           1,068	 	 	 	              227	 	 	 	                47	 	 	 	              586	 	 	 	         1,012	 	 	 	         1,188	 	 	 	         1,212	 	
 	    (19)	 	 Stock option expense	 	                -	 	 	 	                -	 	 	 	            215	 	 	 	           1,211	 	 	 	           4,665	 	 	 	           7,303	 	 	 	           8,639	 	 	 	         7,762	 	 	 	         8,376	 	 	 	         8,130	 	
 	    (20)	 	 Lawsuit settlement	 	                -	 	 	 	         3,135	 	 	 	       17,350	 	 	 	              272	 	 	 	           1,927	 	 	 	                  -	 	 	 	              882	 	 	 	         1,853	 	 	 	         2,299	 	 	 	         1,016	 	
 	    (21)	 	 Debt registration expenses	 	                -	 	 	 	         1,191	 	 	 	                -	 	 	 	                  -	 	 	 	                  -	 	 	 	                  -	 	 	 	                  -	 	 	 	                -	 	 	 	                -	 	 	 	                -	 	
 	    (22)	 	 VITAS transactions costs	 	                -	 	 	 	            442	 	 	 	          (959	) 	 	 	                  -	 	 	 	                  -	 	 	 	                  -	 	 	 	                  -	 	 	 	                -	 	 	 	                -	 	 	 	                -	 	
 	    (23)	 	 Prior-period insurance adjustments	 	                -	 	 	 	                -	 	 	 	       (1,663	) 	 	 	                  -	 	 	 	                  -	 	 	 	              597	 	 	 	                  -	 	 	 	                -	 	 	 	                -	 	 	 	                -	 	
 	    (24)	 	 Expenses associated with contested proxy solicitation	 	                -	 	 	 	                -	 	 	 	                -	 	 	 	                  -	 	 	 	                  -	 	 	 	                  -	 	 	 	           3,989	 	 	 	                -	 	 	 	                -	 	 	 	                -	 	
 	    (25)	 	 Acquisition Expenses	 	                -	 	 	 	                -	 	 	 	                -	 	 	 	                  -	 	 	 	                  -	 	 	 	                  -	 	 	 	                  -	 	 	 	            324	 	 	 	            121	 	 	 	            188	 	
 	    (26)	 	 Costs to Shut down HVAC operations	 	                -	 	 	 	                -	 	 	 	                -	 	 	 	                  -	 	 	 	                  -	 	 	 	                  -	 	 	 	                  -	 	 	 	                -	 	 	 	                -	 	 	 	         1,126	 	
 	    (27)	 	 Securities litigation	 	                -	 	 	 	                -	 	 	 	                -	 	 	 	                  -	 	 	 	                  -	 	 	 	                  -	 	 	 	                  -	 	 	 	                -	 	 	 	                -	 	 	 	            742	 	
 	    (28)	 	 Other	 	                -	 	 	 	                -	 	 	 	                -	 	 	 	            (467	) 	 	 	            (467	) 	 	 	                  -	 	 	 	                  -	 	 	 	                -	 	 	 	                -	 	 	 	                -	 	
 	    (29)	 	 Adjusted EBITDA	$ 	 25,118	 	 	$ 	 91,950	 	 	$ 	 120,513	 	 	$	 131,373	 	 	$ 	 161,846	 	 	$ 	  161,754	 	 	$	 177,050	 	 	$ 	 189,395	 	 	$ 	 197,273	 	 	$	 201,455	 	
 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	
Reconciliation of Adjusted Net Income	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	
 	    (30)	 	 Net income/(loss)	$ 	 (3,435	) 	 	$	 27,512	 	 	$ 	  35,817	 	 	$ 	 50,651	 	 	$ 	   61,641	 	 	$ 	  67,281	 	 	$ 	  73,784	 	 	$ 	  81,831	 	 	$ 	 85,979	 	 	$ 	 89,304	 	
 	 	 	 Add/(deduct):	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	
 	    (31)	 	 Discontinued operations	 	       14,623	 	 	 	       (8,417	) 	 	 	            411	 	 	 	           7,071	 	 	 	         (1,201	) 	 	 	           1,088	 	 	 	              253	 	 	 	                -	 	 	 	                -	 	 	 	                -	 	
 	    (32)	 	 (Gains)/losses on investments	 	       (3,351	) 	 	 	                -	 	 	 	                -	 	 	 	              918	 	 	 	                  -	 	 	 	                  -	 	 	 	                  -	 	 	 	                -	 	 	 	                -	 	 	 	                -	 	
 	    (33)	 	 Gain on sale of property	 	                -	 	 	 	                -	 	 	 	                -	 	 	 	                  -	 	 	 	            (724	) 	 	 	                  -	 	 	 	                  -	 	 	 	                -	 	 	 	                -	 	 	 	                -	 	
 	    (34)	 	 Impairment loss on transportation equipment	 	                -	 	 	 	                -	 	 	 	                -	 	 	 	                  -	 	 	 	                  -	 	 	 	           1,714	 	 	 	                  -	 	 	 	                -	 	 	 	                -	 	 	 	                -	 	
 	    (35)	 	 Severance charges	 	         2,358	 	 	 	                -	 	 	 	                -	 	 	 	                  -	 	 	 	                  -	 	 	 	                  -	 	 	 	                  -	 	 	 	                -	 	 	 	                -	 	 	 	                -	 	
 	    (36)	 	 Dividend income from VITAS	 	       (1,379	) 	 	 	                -	 	 	 	                -	 	 	 	                  -	 	 	 	                  -	 	 	 	                  -	 	 	 	                  -	 	 	 	                -	 	 	 	                -	 	 	 	                -	 	
 	    (37)	 	 Equity in earnings of VITAS	 	          (922	) 	 	 	         4,105	 	 	 	                -	 	 	 	                  -	 	 	 	                  -	 	 	 	                  -	 	 	 	                  -	 	 	 	                -	 	 	 	                -	 	 	 	                -	 	
 	    (38)	 	 Long-term incentive compensation	 	                -	 	 	 	         5,437	 	 	 	         3,434	 	 	 	                  -	 	 	 	           4,427	 	 	 	                  -	 	 	 	           3,134	 	 	 	         2,957	 	 	 	         1,880	 	 	 	            228	 	
 	    (39)	 	 Loss/(gain) on extinguishment of debt	 	                -	 	 	 	         2,030	 	 	 	         2,523	 	 	 	              273	 	 	 	           8,778	 	 	 	         (2,156	) 	 	 	                  -	 	 	 	                -	 	 	 	                -	 	 	 	                -	 	
 	    (40)	 	 Legal expenses of OIG investigation	 	                -	 	 	 	                -	 	 	 	            397	 	 	 	              662	 	 	 	              141	 	 	 	                28	 	 	 	              363	 	 	 	            627	 	 	 	            737	 	 	 	            752	 	
 	    (41)	 	 Stock option expense	 	                -	 	 	 	                -	 	 	 	            137	 	 	 	              769	 	 	 	           2,962	 	 	 	           4,619	 	 	 	           5,464	 	 	 	         4,909	 	 	 	         5,298	 	 	 	         5,143	 	
 	    (42)	 	 Lawsuit settlement	 	                -	 	 	 	         1,897	 	 	 	       10,757	 	 	 	              169	 	 	 	           1,168	 	 	 	                  -	 	 	 	              534	 	 	 	         1,126	 	 	 	         1,397	 	 	 	            617	 	
 	    (43)	 	 Prior period tax adjustments	 	                -	 	 	 	       (1,620	) 	 	 	       (1,961	) 	 	 	         (2,115	)	 	 	                  -	 	 	 	            (322	) 	 	 	                  -	 	 	 	                -	 	 	 	                -	 	 	 	                -	 	
 	    (44)	 	 Debt registration expenses	 	                -	 	 	 	            727	 	 	 	 	 	 	 	                  -	 	 	 	                  -	 	 	 	                  -	 	 	 	                  -	 	 	 	                -	 	 	 	                -	 	 	 	                -	 	
 	    (45)	 	 VITAS transactions costs	 	                -	 	 	 	            222	 	 	 	          (959	) 	 	 	                  -	 	 	 	                  -	 	 	 	                  -	 	 	 	                  -	 	 	 	                -	 	 	 	                -	 	 	 	                -	 	
 	    (46)	 	 Prior-period insurance adjustments	 	                -	 	 	 	                -	 	 	 	       (1,014	) 	 	 	                  -	 	 	 	                  -	 	 	 	              358	 	 	 	                  -	 	 	 	                -	 	 	 	                -	 	 	 	                -	 	
 	    (47)	 	 Non-cash interest on convertible debt	 	                -	 	 	 	                -	 	 	 	                -	 	 	 	                  -	 	 	 	           2,335	 	 	 	           3,228	 	 	 	           3,988	 	 	 	         4,313	 	 	 	         4,664	 	 	 	         5,041	 	
 	    (48)	 	 Income tax impact of non-taxable investments	 	                -	 	 	 	                -	 	 	 	                -	 	 	 	                  -	 	 	 	                46	 	 	 	           3,062	 	 	 	            (756	) 	 	 	                -	 	 	 	                -	 	 	 	                -	 	
 	    (49)	 	 Expenses associated with contested proxy solicitation	 	                -	 	 	 	                -	 	 	 	                -	 	 	 	                  -	 	 	 	                  -	 	 	 	                  -	 	 	 	           2,525	 	 	 	                -	 	 	 	                -	 	 	 	                -	 	
 	    (50)	 	 Acquisition Expenses	 	                -	 	 	 	                -	 	 	 	                -	 	 	 	                  -	 	 	 	                  -	 	 	 	                  -	 	 	 	                  -	 	 	 	            198	 	 	 	              75	 	 	 	            114	 	
 	    (51)	 	 Costs to Shut down HVAC operations	 	                -	 	 	 	                -	 	 	 	                -	 	 	 	                  -	 	 	 	                  -	 	 	 	                  -	 	 	 	                  -	 	 	 	                -	 	 	 	                -	 	 	 	            649	 	
 	    (52)	 	 Securities litigation	 	                -	 	 	 	                -	 	 	 	                -	 	 	 	                  -	 	 	 	                  -	 	 	 	                  -	 	 	 	                  -	 	 	 	                -	 	 	 	                -	 	 	 	            469	 	
 	    (53)	 	 Other	 	                -	 	 	 	                -	 	 	 	                -	 	 	 	            (296	) 	 	 	            (296	) 	 	 	                  -	 	 	 	                  -	 	 	 	                -	 	 	 	                -	 	 	 	                -	 	
 	    (54)	 	 Adjusted net income	$ 	 7,894	 	 	$	 31,893	 	 	$ 	 49,542	 	 	$ 	 58,102	 	 	$	  79,277	 	 	$ 	   78,900	 	 	$ 	 89,289	 	 	$ 	 95,961	 	 	$ 	 100,030	 	 	$ 	  102,317	 	
 
\
 
3

 

 
PROXY STATEMENT
 
This Proxy Statement and the accompanying proxy card are furnished in connection with the solicitation by the Board of Directors (the “Board” or the “Board of Directors”) of Chemed Corporation (the “Company” or “Chemed”) of proxies to be used at the Annual Meeting of Stockholders of the Company to be held at 11:00 a.m. Eastern Time at The Queen City Club, 331 East Fourth Street, Cincinnati, Ohio, on May 20, 2013 (the “Annual Meeting”), and any adjournments or postponements thereof.  The Company’s mailing address is Suite 2600, 255 East Fifth Street, Cincinnati, Ohio 45202-4726.  The approximate date on which this Proxy Statement and the enclosed proxy card are first being given or sent to stockholders is April 5, 2013.

The Board unanimously recommends that you vote FOR the election of each of the Board’s nominees named on the proxy card accompanying this Proxy Statement.   Please read “How to Vote” for more information on how to vote your proxy.
 
STOCKHOLDERS ENTITLED TO VOTE

Stockholders as recorded in the Company’s stock register on March 28, 2013 will be entitled to notice of and may vote at the Annual Meeting or any adjournments or postponements thereof.  On such date, the Company had outstanding 18,865,008 shares of capital stock, par value $1 per share (“Capital Stock”), entitled to one vote per share.  The list of stockholders entitled to vote at the meeting will be open to the examination of any stockholder for any purpose relevant to the meeting during normal business hours for 10 days before the meeting at the Company’s office in Cincinnati.  The list will also be available during the meeting for inspection by stockholders.
 
QUORUM

The Company’s bylaws provide that at all meetings of stockholders, the holders of record, present in person or by proxy, of shares of Capital Stock having a majority of the voting power entitled to vote thereat, is necessary and sufficient to constitute a quorum for the transaction of business.  Abstentions and shares held of record by a broker or its nominee that are voted on any matter are included in determining the number of votes present.  Broker shares that are not voted on any matter at the Annual Meeting will not be included in determining whether a quorum is present.

Your vote is important – we urge you to vote by proxy even if you plan to attend the Annual Meeting.

4

 

VOTE REQUIREMENTS

 
 
Proposal	 

Vote Required	 

Voting Options	 
 
Effect of
Abstentions	Broker
Discretionary
Voting
Allowed?	 
Effect of
Broker
Non-Votes	 
 
Recommended
Vote	
Election of Directors
(Proposal 1)	Votes cast for exceed votes
cast against	FOR, AGAINST
or ABSTAIN
 	No effect, not
treated as a
“vote cast”	No	No effect, not
treated as a
“vote cast”	FOR	
Ratification of Auditor
Appointment
(Proposal 2)	Majority of shares with
voting power present in
person or represented by
proxy	FOR, AGAINST
or ABSTAIN	Treated as a vote
AGAINST the
proposal
 	Yes	Not applicable	FOR	
Non-Binding
Advisory Vote on
Executive
Compensation
(Say on Pay)
(Proposal 3)
 	Majority of shares with
voting power present in
person or represented by
proxy	FOR, AGAINST
or ABSTAIN	Treated as a vote
AGAINST the
proposal	No	No effect – not
entitled to vote	FOR	
 
HOW TO VOTE; SUBMITTING YOUR PROXY; REVOKING YOUR PROXY

You may vote your shares either by voting in person at the Annual Meeting or by submitting a completed proxy.  By submitting a proxy, you are legally authorizing another person to vote your shares.  The enclosed proxy card designates Messrs. McNamara and Walsh to vote your shares in accordance with the voting instructions you indicate on your proxy card.

If you submit your executed proxy card designating Messrs. McNamara and Walsh as the individuals authorized to vote your shares, but you do not indicate how your shares are to be voted, then your shares will be voted by these individuals in accordance with the Board’s recommendations, which are described in this Proxy Statement.  In addition, if any other matters are properly brought up at the Annual Meeting (other than the proposals contained in this Proxy Statement), then each of these individuals will have the authority to vote your shares on those other matters in accordance with his or her discretion and judgment.  The Board currently does not know of any matters to be raised at the Annual Meeting other than the proposals contained in this Proxy Statement.

We urge you to vote by doing one of the following:
 
·  	Vote by Mail:  You can vote your shares by mail by completing, signing, dating and returning your proxy card in the postage-paid envelope provided.  In order for your proxy to be validly submitted and for your shares to be voted in accordance with your instructions, we must  receive  your mailed proxy card by 11:59 p.m. Central Time on May 19, 2013.	
 
·  	Vote by Telephone:  You can also vote your shares by calling the number (toll-free in the United States and Canada) indicated on your proxy card at any time and following the recorded instructions.  If you submit your proxy by telephone, then you may submit your voting instructions up until 11:59 p.m. Central Time on May 19, 2013.  If you are a beneficial owner, or you hold your shares in “street name” as described below, please contact your bank, broker or other holder of record to determine whether you will be able to vote by telephone.	
 
·  	Vote via the Internet:  You can vote your shares via the Internet by going to the Web site address for Internet voting indicated on your proxy card   and following the steps outlined on the secure Web site.  If you submit your proxy via the Internet, then you may submit your voting instructions up until 11:59 p.m. Central Time on May 19, 2013.  If you are a beneficial owner, or you hold your shares in “street name”, please contact your bank, broker or other holder of record to determine whether you will be able to vote via the Internet.	
 
If your shares are not registered in your name but in the “street name” of a bank, broker or other holder of record (a “nominee”), then your name will not appear in the Company’s register of stockholders. Those shares are held in your nominee’s name, on your behalf, and your nominee will be entitled to vote your shares. Your nominee is required to vote your shares in accordance with your instructions.  If you do not give instructions to your nominee, your nominee will be entitled to vote your shares with respect to “discretionary” items but will not be permitted to vote your shares with respect to “non-discretionary” items (your shares are treated as “broker non-votes”).

5

 
 
Your proxy is revocable.  If you are a stockholder of record, after you have submitted your proxy card, you may revoke it by mail by sending a written notice to be delivered before the Annual Meeting to the Company’s Secretary at Suite 2600, 255 East Fifth Street, Cincinnati, Ohio 45202-4726.  If you wish to revoke your submitted proxy card and submit new voting instructions by mail, then you must sign, date and mail a new proxy card with your new voting instructions, which we must receive by 11:59 p.m. Central Time on May 19, 2013.  If you are a stockholder of record and you voted your proxy card by telephone or via the Internet, you may revoke your submitted proxy and/or submit new voting instructions by that same method, which must be received by 11:59 p.m. Central Time on May 19, 2013.  You also may revoke your proxy card by attending the Annual Meeting and voting your shares in person. Attending the Annual Meeting without taking one of the actions above will not revoke your proxy.  If you are a beneficial owner, or you hold your shares in “street name” as described above, please contact your bank, broker or other holder of record for instructions on how to change or revoke your vote.

Your vote is very important to the Company.  If you do not plan to attend the Annual Meeting, we encourage you to read this Proxy Statement and submit your completed proxy card prior to the Annual Meeting in accordance with the above instructions so that your shares will be represented and voted in accordance with your instructions.   Even if you plan to attend the Annual Meeting in person, we recommend that you vote your shares in advance as described above so that your vote will be counted if you later decide not to attend the Annual Meeting.

You are entitled to attend the Annual Meeting only if you are a stockholder of record or a beneficial owner as of the close of business on March 28, 2013, or if you hold a valid proxy for the meeting.  You should be prepared to present photo identification for admission.

If your shares are held in “street name”, in order for you to attend the Annual Meeting, you must bring a letter or account statement showing that you beneficially own the shares held by your nominee, as well as proper photo identification.  Note that even if you attend the Annual Meeting, you cannot vote the shares that are held by your nominee unless you have a proxy from your nominee.  Rather, you should vote your shares by following the instructions provided on the enclosed proxy card and returning the proxy card to your nominee to ensure that your shares will be voted on your behalf, as described above.

If you have questions or require any assistance with voting your shares, please contact the Company’s transfer agent, Wells Fargo Shareowner Services at 1-800-468-9716.

ELECTION OF DIRECTORS
 
In the election of directors, every stockholder has the right to vote each share of Capital Stock owned by such stockholder on the record date for as many persons as there are directors to be elected.  Ten directors are to be elected at the Annual Meeting to serve until the next Annual Meeting of Stockholders and until their successors are duly elected and qualified in accordance with our bylaws.  Cumulative voting is not permitted.  To be elected in an uncontested election, each director must receive the affirmative vote of the majority of the votes cast at the Annual Meeting.  The number of votes cast “FOR” a nominee’s election must exceed the number of votes cast ‘AGAINST’ his or her election.  Abstentions and broker non-votes shall not be counted as votes cast.
 
As required by the Company’s bylaws, each incumbent director nominee has submitted an irrevocable letter of resignation as director that becomes effective if he or she does not receive the affirmative vote of the majority of the votes cast at the Annual Meeting and the Board of Directors accepts the resignation.  If an incumbent director is not re-elected, the Nominating Committee will consider the director’s resignation and recommend to the Board of Directors the action to be taken with respect to such resignation.  The Board of Directors will decide the action to be taken with respect to such resignation no later than 90 days following the certification of the voting results.  The Company will publicly disclose the Board of Directors’ decision within four business days, providing an explanation of the process by which the decision was reached and, if applicable, the reason for not accepting the director’s resignation.  Any director whose resignation is so evaluated and decided upon will not participate in the Nominating Committee’s recommendation or Board of Directors’ action regarding whether to accept the resignation offer.

6

 
 
NOMINEES
 
Unless otherwise indicated by your proxy card, if you return a validly completed and executed proxy card or vote your proxy card by telephone or via the Internet, your shares will be voted FOR the nominees named below.  Each of the nominees named below is a current director standing for re-election, and each was elected at the Annual Meeting of Stockholders held on May 21, 2012.  As of the date of this Proxy Statement, the Board has no reason to believe that any of the nominees named below will be unable or unwilling to serve.  Each nominee named below has consented to being named in this Proxy Statement and to serve if elected.
 
The following paragraphs provide information as of the date of this proxy statement about each nominee.  As discussed in “Corporate Governance – Committees and Meetings of the Board – Nominating Committee” below, the Board seeks independent directors who represent a mix of backgrounds and experiences that will enhance the quality of the Board’s deliberations and decisions.  Candidates shall have substantial experience or shall have achieved a high level of distinction in their fields.  Certain individual qualifications and skills of our nominees that contribute to the Board’s effectiveness as a whole in performing its oversight responsibilities are described below.

Kevin J. McNamara
Director since 1987
Age: 59	Mr. McNamara’s experience, qualifications, attributes and skills include serving as President and Chief Executive Officer of the Company.  He has held these positions since August 1994 and May 2001, respectively.  Previously, he served as Executive Vice President, Secretary and General Counsel from November 1993, August 1986 and August 1986, respectively, to August 1994.
 	
Joel F. Gemunder
Director since 1977
Age: 73	Mr. Gemunder’s experience, qualifications, attributes and skills include having served as President and Chief Executive Officer of Omnicare, Inc., Cincinnati, Ohio (healthcare products and services) (“Omnicare”).  Omnicare is a leading provider of pharmaceutical care for seniors serving more than 1.4 million residents of skilled nursing, assisted living, and other healthcare facilities in 47 states and Canada. He retired from these positions in August 2010, having served since May 1981 and May 2001, respectively.  Omnicare is a former equity investee of the Company that became a publicly owned corporation in 1981 and has not been a Chemed affiliate since at least 1996.  He is also a director of Ultratech Stepper, Inc. (advanced packaging and laser processing, San Jose, California) and was a director of Omnicare until his August 2010 retirement.
 	
Patrick P. Grace
Director since 1996
Age: 57	Mr. Grace’s experience, qualifications, attributes and skills include serving in various executive positions at W.R. Grace & Co. from 1977 to 1995, most recently as President and CEO of Grace Logistics, Inc.  He was the co-founder and managing Principal of Apollo Philanthropy Partners, L.L.C., New York, New York (philanthropic advisory services) from 2008 to 2012.  From 1996 to present he serves as President of MLP Capital, Inc., New York, New York, an investment holding company which has had several real estate and mining interests in the southeastern United States.  Since 2008 he has served as Chairman of the board of KickStart International, a global anti-poverty organization.  He also serves as a director of TONIX Pharmaceuticals, Inc., New York, New York (specialty pharmaceutical product development and commercialization).  He earned a Master’s of Business Administration degree in finance from Columbia University.
 	
Thomas C. Hutton
Director since 1985
Age: 62	Mr. Hutton’s experience, qualifications, attributes and skills include serving as a Vice President of the Company.  He has held this position since February 1988.  Previously, Mr. Hutton, who has a J.D. and Master’s of Public Administration degree from Cornell University, practiced corporate law in New York concentrating in securities and regulatory law from 1977 to 1987.  He served as a director of Omnicare from May 1983 to May 2001.  Currently Mr. Hutton serves as a trustee on three private foundations including the Chemed Foundation.

 
7

 
 
Walter L. Krebs
Director from May 1989 to
April 1991, May 1995 to
May 2003 and since May 2005
Age: 80	Mr. Krebs’ experience, qualifications, attributes and skills include having served as Senior Vice President-Finance, Chief Financial Officer and Treasurer of Service America Systems, Inc. (home and service warranties), a then-wholly owned subsidiary of the Company (“Service America”).  We sold Service America in 2005.  He retired from this position in July 1999, having held the position since October 1997.  Previously, he was a Director-Financial Services of DiverseyLever, Inc. (formerly known as Diversey Corporation), Detroit, Michigan (specialty chemicals) (“Diversey”), from April 1991 to April 1996.  Previously, from January 1990 to April 1991, he was Senior Vice President and the Chief Financial Officer of the Company’s then-wholly owned subsidiary, DuBois Chemicals, Inc. (specialty chemicals) (“DuBois”).  We sold DuBois in 1991.
 	
Andrea R. Lindell
Director since May 2008
Age: 69	Ms. Lindell’s experience, qualifications, attributes and skills include having served as Dean and a Professor of the College of Nursing at the University of Cincinnati.  She retired from these positions in January 2011 having held them since December 1990.  She is currently Professor Emeritus at the college, and since August 2011, Interim Associate Dean and Director of the doctoral program at the School of Nursing, Walden University.  Walden offers online degrees as follows: BSN, MSN, DNP.  Ms. Lindell was also Associate Senior Vice President of the Medical Center at the University of Cincinnati from July 1998 until January 2011.  The College of Nursing’s programs include over 1,500 students, and offer the following degrees: BSN, MSN, Post MSN, and PhD.  From September 1994 to June 2002, she also held an additional position as Founder and Interim Dean of the College of Allied Health Sciences at the University of Cincinnati.  She is a director of Omnicare.
 	
Thomas P. Rice
Director since May 2009
Age: 63	Mr. Rice’s experience, qualifications, attributes and skills include having served as  Chief Executive Officer of Andrx Corporation, Fort Lauderdale, Florida (specialty pharmaceuticals) (“Andrx”), from February 2004 to November 2006, when Andrx was sold to Watson Pharmaceuticals.  Following the sale, Mr. Rice returned as General Manager and Partner to Columbia Investments LLC, Baltimore, Maryland, which invests in local businesses in Baltimore and which Mr. Rice co-founded in January 1996.  He was also a Director of Par Pharmaceuticals, Woodcliff Lake, NJ (drug development, manufacture, and marketing) until November 2012.  From January 1999 to March 2003, he was President and Chief Executive Officer of Chesapeake Biological Laboratories, Inc., Solomons, Maryland (pharmaceuticals manufacturing) (“Chesapeake”).  Before co-founding Columbia Investments LLC, Mr. Rice served as Executive Vice President and Chief Operating Officer of Circa Pharmaceuticals, Inc., Copiague, New York (pharmaceuticals manufacturing) (“Circa”), from June 1993 to January 1996.  Mr. Rice was also the Chief Financial Officer of Circa from June 1993 to January 1995.  Prior to joining Circa, Mr. Rice spent seven years as an accountant with Deloitte & Touche LLP, an international accounting firm. He earned a Master’s degree in finance from Loyola University.  He was a director of Circa from June 1993 to January 1996, a director of Chesapeake from January 1997 to January 1999 and a director of Andrx from April 2003 to November 2006.
 	
Donald E. Saunders
Director from May 1981 to
May 1982, May 1983 to
May 1987 and since May 1998
Age: 68	Mr. Saunders’ experience, qualifications, attributes and skills include serving as a Professor at the Farmer School of Business, Miami University, Oxford, Ohio. He has held this position since August 2001.  Miami University is a public university with a student population of 16,000.  He earned a doctorate in Economics, with a minor in Accounting, from Indiana University.  He has taken Masters level courses in financial reporting, financial valuation, and risk management.  Mr. Saunders retired as President of DuBois, then a division of Diversey, in October 2000, having held that position since November 1993.

George J. Walsh III
Director since 1995
Age: 67	Mr. Walsh’s experience, qualifications, attributes and skills include serving as a partner with the law firm of Thompson Hine LLP, New York, New York.  He has held this position since May 2002.  Prior to this date, Mr. Walsh was a partner with the law firm of Gould & Wilkie LLP, New York, New York, and held this position since January 1979.  Gould & Wilkie merged with Thompson Hine on May 1, 2002.  Mr. Walsh was elected the Chairman of the Board of Directors in March 2009.
 	
Frank E. Wood
Director since 2002
Age: 70	Mr. Wood’s experience, qualifications, attributes and skills include serving as President and Chief Executive Officer of Secret Communications, LLC, Cincinnati, Ohio (former owner and operator of radio stations, and now a venture capital fund).  He has held this position since 1994.  He is also co-founder and principal of The Darwin Group, Cincinnati, Ohio (venture capital firm specializing in second-stage investments), and has held this position since 1998.  Since 2000, he has also served as chairman of 8e6 Technologies Corporation, Orange, California (developer of Internet filtering software).  He is also a director of Tribune Company, Chicago, Illinois.  He earned a J.D. degree from The University of Chicago Law School.	

8

 
 
The Board unanimously recommends that you vote FOR the election of each of the above-named nominees.

CORPORATE GOVERNANCE
Director Compensation
 
The Company’s compensation program for directors who are not employees of the Company consists of annual cash fees and fully vested stock awards granted pursuant to the Chemed Corporation 2006 Stock Incentive Plan (as amended, supplemented or otherwise modified as of the date hereof, the “2006 Incentive Plan”) and the Chemed Corporation 2010 Stock Incentive Plan (as amended, supplemented or otherwise modified as of the date hereof, the “2010 Incentive Plan”).  Directors who are not employees of the Company may also participate in the Chemed Corporation Deferred Compensation Plan for Non-Employee Directors (the “Director Deferred Compensation Plan”), which is described below.  Directors who are employees of the Company do not receive cash compensation for their service as directors, and do not receive annual fully vested stock awards for such service.
 
The Board reviews and sets the cash compensation and fully vested stock awards for non-employee directors.  In making its determination, the Board seeks input from the Compensation Committee’s independent compensation consultant, Compensation Strategies, Inc., as well as certain executive officers of the Company, and considers any such input, including as to the level of compensation necessary to attract and retain qualified directors, among the factors it reviews in setting the amount of compensation.  Director compensation is generally reviewed by the Board on an annual basis.  It was most recently reviewed in May of 2011.
 
During 2012, each member of the Board of Directors who is not an employee of the Company is paid an annual fee of $45,000 and a fee of $3,000 for each Board meeting attended.  Non-employee directors also receive annual fully vested stock awards in the amount of $60,000.  Mr. Walsh is paid an additional annual fee of $145,000 for his service as Chairman of the Board.  Each member of the Board’s Audit Committee (other than its chairman), Compensation/Incentive Committee (the “Compensation Committee”) (other than its chairman) and Nominating Committee (including its chairman) is paid an additional annual fee of $10,000, $7,000 and $7,000, respectively, for his or her service on that Committee.  The chair of the Audit Committee is paid $25,000 per year, and the chair of the Compensation Committee is paid $7,500 per year.  The Audit Committee also served as a special committee in 2012 investigating certain matters.  A Committee member also is paid $1,000 for each Committee meeting (other than meetings of the Nominating Committee) attended unless the Committee meeting is on the same day as a meeting of the Board of Directors, in which case Committee members are paid $500 for attendance at the Committee meeting.  Messrs. McNamara and Hutton, who are employees of the Company, do not receive compensation for their service as directors.  Each member of the Board of Directors and of a Committee is additionally reimbursed for continuing education expenses and reasonable travel expenses incurred in connection with attendance at Board and Committee meetings.
 
In May 2012, Messrs. Gemunder, Grace, Krebs, Rice, Saunders and Wood and Ms. Lindell each received $60,045 in the form of a fully vested stock award of 1,086 shares of Capital Stock.  Mr. Walsh also received the cash equivalent of a fully vested stock award of 1,086 shares of Capital Stock, or $60,045.
 
In addition, the Company maintains the Director Deferred Compensation Plan in which certain directors who are not employees of the Company or of a subsidiary of the Company participate.  Under such plan, which is not a tax-qualified plan, an account is established for each participant to whom amounts are credited quarterly at the rate of $6,000 per year.  These amounts are used to purchase shares of Capital Stock, and all dividends are reinvested in Capital Stock.  Each participant is entitled to receive the balance in his or her account within 90 days following the date he or she ceases to serve as a director.  In 2012, each of Messrs. Gemunder, Grace, Krebs, Rice, Saunders, Walsh and Wood and Ms. Lindell received contributions of $6,000, in each case in his or her respective account in the Director Deferred Compensation Plan.
 
Directors may participate in the Company’s health insurance plans by paying rates offered to former employees under COBRA.

9

 
 
In 2012, the Company provided the following compensation to directors and directors emeriti for their service to the Company:
 
DIRECTOR COMPENSATION-2012 (a)

 
Directors Emeriti
 
The Board of Directors has a policy of conferring the honorary designation of Director Emeritus upon former directors who made valuable contributions to the Company and whose continued advice is believed to be of value to the Board of Directors.  The designation as Director Emeritus is customarily conferred by the Board on an annual basis but may be conferred at such other times and for such other periods as the Board may determine.  Each Director Emeritus is furnished with a copy of all agendas and other materials furnished to members of the Board of Directors generally, and is invited to attend all meetings of the Board; however, a Director Emeritus is not entitled to vote on any matters presented to the Board.  A Director Emeritus is paid an annual fee of $18,000 and $500 for each meeting attended.
 
Ms. Laney, who served as a director of the Company from 1986-2009, was initially designated a Director Emeritus in May 2009 and has been so designated in each subsequent May.  In 2012, the Company paid Ms. Laney $22,000 in cash fees and granted her $60,045 in the form of a fully vested stock award of 1,086 shares of Capital Stock in her capacity as a Director Emeritus.
 
Majority Voting in Director Elections
 
In March 2013, the Company amended its bylaws to implement a majority voting standard for uncontested elections of directors.  As described above under “Elections,” each director must receive the affirmative vote of the majority of the votes cast to be elected in an uncontested election.  Each incumbent director nominee has submitted an irrevocable letter of resignation as director that becomes effective if he or she does not receive the affirmative vote of the majority of the votes cast in an uncontested election and the Board of Directors accepts the resignation.  In contested elections, each director must receive a plurality of the votes cast.  An election is contested if (a) a stockholder has nominated any person(s) for election to the Board of Directors in compliance with our bylaws or otherwise in accordance with applicable law and (b) such nomination has not been withdrawn on or prior to the fourteenth day prior to the date the Company first mails its notice of meeting.

10

 
 
Committees and Meetings of the Board
 
The Company has the following Committees of the Board of Directors: Audit Committee, Compensation Committee and Nominating Committee.
 
Audit Committee The Audit Committee (a) is directly responsible for the appointment, compensation and oversight of a firm of independent registered accountants to audit the consolidated financial statements of the Company, (b) reviews and reports to the Board of Directors on the Company’s annual financial statements and the independent accountants’ report on such financial statements, (c) meets with the Company’s senior financial officers, internal auditors and independent accountants to review audit plans and work regarding the Company’s accounting, financial reporting and internal control systems and other non-audit services and (d) confers quarterly with senior management, internal audit staff and the independent accountants to review quarterly financial results.  Each member of the Audit Committee is independent as defined under the listing standards of the New York Stock Exchange.  A copy of the Audit Committee Charter is available at www.chemed.com.
 
Compensation Committee  The executive compensation program is administered by the Compensation Committee.  The Compensation Committee makes recommendations to the Board of Directors concerning (a) base salary and annual cash incentive compensation for executives of the Company, (b) establishment of incentive compensation plans and programs generally, (c) adoption and administration of certain employee benefit plans and programs and (d) additional year-end contributions by the Company under the Chemed/Roto-Rooter Savings & Retirement Plan (as amended, supplemented or otherwise modified as of the date hereof, the “Retirement Plan”).  In addition, the Compensation Committee administers the 1999 Incentive Plan, the 2004 Incentive Plan, the 2006 Incentive Plan, the 2010 Incentive Plan, and the Chemed Corporation 1999 Long-Term Employee Incentive Plan (as amended, supplemented or otherwise modified as of the date hereof, the “1999 Long-Term Incentive Plan” and, collectively with the 1999 Incentive Plan, the 2004 Incentive Plan, the 2006 Incentive Plan, and the 2010 Incentive Plan, the “Stock Incentive Plans”) and the Chemed Corporation 2002 Executive Long-Term Incentive Plan (as amended, supplemented or otherwise modified as of the date hereof, the “LTIP”), under which it reviews and approves the granting of cash, stock options and stock awards.  Each member of the Compensation Committee is independent as defined under the listing standards of the New York Stock Exchange.  A copy of the Compensation Committee Charter is available on the Company’s Web site, www.chemed.com.
 
Nominating Committee  The Nominating Committee (a) recommends to the Board of Directors the candidates for election to the Board at each Annual Meeting of Stockholders of the Company, (b) recommends to the Board of Directors candidates for election by the Board to fill vacancies on the Board, (c) considers candidates submitted to the Committee by directors, officers, employees, stockholders and others and (d) performs such other functions as may be assigned by the Board.  In identifying and evaluating nominees for director, the Nominating Committee considers candidates with a wide variety of academic backgrounds and professional and business experiences.  After reviewing the candidates’ backgrounds and qualifications, the Nominating Committee personally interviews those candidates it believes merit further consideration.  Once it has completed this process, the Nominating Committee makes its final recommendations to the Board.  Stockholders wishing to submit a candidate for election to the Board should submit the candidate’s name and a supporting statement to the Company’s Secretary at Suite 2600, 255 East Fifth Street, Cincinnati, Ohio 45202-4726.  The Nominating Committee has no formal policy with regard to the consideration of director candidates recommended by stockholders because it believes such recommendations are sufficiently rare that they may be effectively considered on a case-by-case basis.  The Nominating Committee considers diversity in identifying nominees.  It assesses the effectiveness of the Company’s diversity policy every year as part of the nomination process for the annual election of directors by the Company stockholders.  Having reviewed the collective background and experience of all nominees, the Board has concluded they provide significant diversity.  Its policy is to select the most appropriate candidate for election.  Board membership should reflect diversity in its broadest sense, including persons diverse in geography, gender, experience, professions, skills and backgrounds.  The Committee does not assign specific weights to particular criteria.  The background and qualifications of all directors, considered as a group, should provide a significant composite mix of experience, knowledge and abilities that allow the Board to fulfill its responsibilities.  Each member of the Nominating Committee is independent as defined under the listing standards of the New York Stock Exchange.  A copy of the Nominating Committee Charter is available on the Company’s Web site, www.chemed.com.
 
The following table shows the current membership of each committee and the number of meetings held by each committee during 2012:

11

 

Director	Audit
Committee*	Compensation
Committee	Nominating
Committee	
J. F. Gemunder
P. P. Grace
W. L. Krebs
A. R. Lindell
T. P. Rice*
D. E. Saunders*
G. J. Walsh III
F. E. Wood	 
x

x
Chair

 
x
x

Chair
x	x
Chair

 
 
x
 	
Number of 2012 Meetings	7	3	1	
 
*Audit Committee Financial Expert as defined by Securities and Exchange Commission regulations.
The Audit Committee also met five times to investigate certain matters.
 
Board Meetings  The Board of Directors has five scheduled meetings a year, at which it reviews and discusses reports by management on the performance of the Company and its operating subsidiaries, its plans and properties, as well as immediate issues facing the Company.  The Board also meets during its meetings in executive session, without executives or management directors present.  Such sessions are presided over by the Chairman of the Board.

During 2012, there were seven meetings of the Board of Directors.  Each director attended at least 75% of the Board meetings and his or her applicable Committee meetings.  While the Company does not have a formal policy with regard to Board members’ attendance at the Annual Meeting of Stockholders, all members of the Board are encouraged to attend.  All members of the Board attended last year’s Annual Meeting of Stockholders held on May 21, 2012.
 
Director Independence  The Board and the Nominating Committee undertake an annual review of director and nominee independence.  They consider transactions and relationships between each director or nominee or any member of such director’s or nominee’s immediate family or any other person sharing such director’s or nominee’s home and the Company and its subsidiaries and affiliates, including those reported under the heading “Certain Relationships and Transactions” below.  The Board and the Nominating Committee also examine transactions and relationships between directors and nominees and their respective affiliates and members of the Company’s senior management and their affiliates.  The purpose of this review is to determine whether any such relationships or transactions are inconsistent with a determination that the director or nominee is independent under the New York Stock Exchange corporate governance listing standards.
 
As a result of its 2013 review, the Board and the Nominating Committee affirmatively determined that, under the New York Stock Exchange listing standards, the following directors and nominees, constituting a majority of the individuals nominated for election as directors at the Annual Meeting, are independent of the Company and its management: Messrs. Gemunder, Grace, Krebs, Rice, Saunders, Walsh and Wood and Ms. Lindell.
 
Risk Oversight  The Board receives periodic reports from management on matters involving risk exposures such as regulatory changes, material litigation, and recommended policy revisions.
 
Management maintains a formal Enterprise Risk Management (ERM) program that monitors management’s actions in response to the key risks facing the Company.  The Audit Committee reviews various aspects of the ERM program periodically throughout the year.  It oversees our risk identification and mitigation process.  It reviews material financial risk exposures including regulatory matters, acquisitions, economic conditions and interest rate exposures.  Members of our management, including our Chief Financial Officer, Chief Legal Officer, Vitas Compliance Officer, and our Director of Internal Audit, report to the Audit Committee regarding on-going risk management process activities. The Audit Committee also reviews legal matters that may have a material impact on the Company’s financial statements.  These Audit Committee reviews are conducted on an annual basis, or more frequently if a significant risk exposure matter develops.

12

 
 
While the Board has responsibility for the Company’s risk oversight, management is responsible for day-to-day risk management processes.  We believe this division of responsibilities most effectively addresses the risks we face, and that our Board leadership structure supports this approach.
 
Compensation Risk  Management has reviewed the compensation policies and practices for our employees and has concluded that they do not create risks that are reasonably likely to have a material adverse effect on us.
 
The Compensation Committee oversees our risks related to compensation programs and philosophy.  It ensures our compensation programs do not encourage excessive risk taking.  It works periodically with our independent compensation consultant to ensure our executive compensation plans are appropriately balanced and incentivize management to act in the best interests of our stockholders.
 
As described in more detail below under “Compensation Discussion and Analysis,” long-term compensation programs for our named executive officers have been structured such that long-term compensation is linked to our long-term relative and absolute performance.  This model of linking long-term compensation to our performance applies not only to our named executive officers, but has also been applied to other senior corporate personnel.  We believe that our compensation plans reflect sound risk management practices and do not encourage excessive or inappropriate risk taking.
 
Compensation Committee Interlocks and Insider Participation  The Compensation Committee is comprised of Messrs. Walsh, Krebs and Wood and Ms. Lindell.  No member of the Compensation Committee has any direct or indirect material interest in or relationship with the Company, other than holdings of Capital Stock as set forth under the heading “Security Ownership of Certain Beneficial Owners and Management” below and as related to his or her position as a director.  During 2012, no executive officer of the Company served on the compensation committee of any other entity where an executive officer of such entity also served on the Board of Directors, and no executive officer of the Company served on the board of directors of any other entity where an executive officer of such entity also served on the Compensation Committee.
 
Board Leadership Structure  The Board has separated the functions of CEO and Chairman of the Board.  Mr. Walsh currently serves as Chairman.  The Board believes this separation of function promotes independence and enhances corporate governance.
 
Policies and Procedures  The Audit Committee reviews all material transactions with related persons as identified by management.  In February 2007, the Audit Committee adopted a written policy and set of procedures for reviewing transactions between the Company and related persons, who include directors, nominees, executive officers and any person known to be the beneficial owner of more than 5% of the Company’s voting securities (each, a “related person”), any immediate family member of a related person and any person sharing the household of a related person.  The policy also covers any firm, corporation or other entity in which any related person is employed or is a partner or principal, or in which such related person has a 5% or greater beneficial ownership interest.  Prior to entering into a transaction with a related person, notice must be given to the Secretary of the Company containing (a) the related person’s relationship to the Company and interest in the transaction, (b) the material facts of the transaction, (c) the benefits to the Company of the transaction, (d) the availability of any other sources of comparable products or services and (e) an assessment of whether the transaction is on terms comparable to those available to an unrelated third party.  If the Company’s Secretary and Chief Financial Officer determine that it is a related party transaction, the proposed transaction is submitted to the Audit Committee for its approval.  The policy also provides for the quarterly review of related person transactions which have not previously been approved or ratified and any other such transactions which come to the attention of the Company’s Chief Executive Officer, Chief Financial Officer, Controller or Secretary.  If the transaction is pending or ongoing, it will be promptly submitted to the Audit Committee for approval.  If the transaction is completed, it will be submitted to the Audit Committee to determine if ratification or rescission is appropriate.  This policy also covers charitable contributions or pledges by the Company to non-profit organizations identified with a related person.
 
Code of Ethics  The Board of Directors has adopted Corporate Governance Principles and Policies on Business Ethics, which, along with the charters of the Audit, Compensation and Nominating Committees, are available on the Company’s Web site under Corporate Governance — Governance Documents (www.chemed.com).  Printed copies may be obtained from the Company’s Secretary at Suite 2600, 255 East Fifth Street, Cincinnati, Ohio 45202-4726.

13

 
 
Stockholder Communications Stockholders and others wishing to communicate with members of the Board should mail such communications to the Company’s Secretary at Suite 2600, 255 East Fifth Street, Cincinnati, Ohio 45202-4726.  The Secretary will forward these communications to the Board and, if applicable, to specified individual directors.
 
EXECUTIVE COMPENSATION
 
Compensation Discussion and Analysis
 
This Compensation Discussion and Analysis explains the material elements of the compensation of the Company’s named executive officers.  The Company’s named executive officers for 2012 are Mr. Kevin J. McNamara, President and Chief Executive Officer; David P. Williams, Executive Vice President and Chief Financial Officer; Timothy S. O’Toole, Executive Vice President; Spencer S. Lee, Executive Vice President; and Arthur V. Tucker, Jr., Vice President and Controller.
 
Consideration of the 2012 Say On Pay Vote
 
Following our 2012 annual meeting of stockholders, the Compensation Committee and the Board of Directors reviewed the results of the non-binding stockholder advisory vote on our executive compensation (“2012 Say On Pay Vote”).  Stockholders voted against Say On Pay, with 51.9% negative votes and 47.7% positive votes.  We believe this negative vote was caused in part by a short-term decline in our stock price beginning in mid-November 2011 that ended in mid-January 2012.  Based on input solicited from stockholders in connection with this vote, as well as our ongoing dialogue with our stockholders, the Compensation Committee and Board adopted significant changes to our executive compensation policies and practices as follows:
 
·  	Changed the timing of the award of stock options from February, the time at which prior year annual incentive compensation is paid, to November of each year.  This will allow the Compensation Committee to take into consideration a greater degree of current year performance in aligning compensation with performance;	
 
·  	Considered the relative impact of awarding stock options as compared to stock awards;	
 
·  	Eliminated the discretionary pool of shares of Capital Stock which the Compensation Committee could award to LTIP recipients upon achievement of either the EBITDA or stock price targets under that plan;	
 
·  	Predetermined amounts to be awarded to the named executive officers pursuant to the LTIP should EBITDA or stock price targets be attained rather than allocating at the time of attainment;	
 
·  	Eliminated the Compensation Committee’s discretion to adjust the amounts paid in annual incentive compensation under the formula of “two times the rate of growth or decline in adjusted earnings per share minus 10%” (“Adjusted EPS” is defined under “Annual Incentive Compensation”).  The Compensation Committee now uses that strict formula, with no discretion, in calculating annual cash incentives for the named executive officers; and	
 
·  	Revised the CD&A presentation in response to the 2012 Say On Pay Vote and in response to comments solicited from stockholders.	
 
Management solicited feedback in connection with this vote from stockholders representing ownership of more than 60% of the total shares outstanding.
 
Overview of Compensation Program
 
The executive compensation program is administered by the Compensation Committee.  The membership of the Compensation Committee is comprised of four independent directors.  The Compensation Committee is responsible for the review, approval and recommendation to the Board of Directors of matters concerning (a) base salary and annual cash incentive compensation for executives of the Company, (b) establishment of incentive compensation plans and programs generally, (c) adoption and administration of certain employee benefit plans and programs, and (d) additional year-end contributions by the Company under the Retirement Plan.  The recommendations of the Compensation Committee on such matters must be approved by the non-employee members of the Board of Directors.  The employee members of the Board of Directors are not present when compensation recommendations are presented to the Board of Directors and discussed, and such members do not vote on compensation issues.  The Compensation Committee also administers the Stock Incentive Plans.  Under authority granted it by those plans, it reviews and approves the granting of stock options and stock awards, and the LTIP.  The Compensation Committee also has retained the services of independent compensation consultants to assist and advise it in administering the executive compensation program.  Currently, Compensation Strategies, Inc., an independent compensation advisory firm, has been retained by, and reports directly and exclusively to, the Compensation Committee.  The scope of these consulting services is limited to (a) advising the Compensation Committee regarding executive compensation, (b) performing studies of general market and peer group compensation levels, and (c) advising the Board on director compensation, all upon request of the Compensation Committee.  Compensation Strategies, Inc., does no other work for the Company outside of providing these compensation advisory services.

14

 
 
How Compensation Decisions Are Made
 
Generally, in February of each year, certain senior executives of the Company, including the Chief Executive Officer, prepare recommendations for annual cash incentives and long-term equity awards to be made to Company employees, other than the Chief Executive Officer, based on the performance of the employees and the Company during the past year.  Beginning in 2013, the Compensation Committee will consider granting stock option awards and/or stock awards in November rather than February, to more fully reflect the Company’s financial and stock price performances during that year.  The recommendations made by the Chief Executive Officer and other senior executives to the Compensation Committee, which include detailed memoranda and tally sheets, take into consideration historical compensation, including base salaries, annual incentive compensation and long-term equity awards, performance of the Company as a whole, performance of the individual business unit for which the employee is responsible and performance of the individual employee.  The Compensation Committee then meets to determine the long-term equity awards for each executive and to review and consider the recommendations prepared by the Company’s senior executives in order to determine the recommendations that the Compensation Committee will make to the non-employee members of the Board of Directors with respect to the amount of annual cash incentives for each executive.  The Compensation Committee makes compensation recommendations to the non-employee members of the Board of Directors regarding the compensation of the Chief Executive Officer without the input of any Company employees.  The Compensation Committee can modify any recommendations of the Company’s senior executives.
 
Base salaries of executives are reviewed generally by the Compensation Committee every 14 months, as this results in reduced compensation expense as compared with 12-month review cycles, and approved by the non-employee members of the Board of Directors.  As a component of the review and approval process, the Compensation Committee and the non-employee members of the Board consider the recommendations of the Chief Executive Officer and certain senior executives of the Company as to the base salaries of Company executives, other than the Chief Executive Officer.  The Chief Executive Officer’s base salary is reviewed and determined without the input of Company employees.  In determining recommended base salaries for the Company’s executives, as more fully discussed under “Base Salaries” below, the Compensation Committee also considers each executive’s then-current base salary and the individual performance of each executive during the then-past 14-month period.
 
The Compensation Committee directly grants compensation, such as cash, stock options and stock awards, under the Stock Incentive Plans and the LTIP.
 
Role of Executive Officers
 
The Chief Executive Officer and certain other senior executives of the Company provide recommendations to the Compensation Committee concerning compensation of Company executives, other than the Chief Executive Officer.  Additionally, as part of its process, the Compensation Committee meets with the Chief Executive Officer to obtain input with respect to compensation decisions, including the performance of the Company’s senior executives other than the Chief Executive Officer.  In addition to meeting with the Chief Executive Officer, the Compensation Committee meets in executive session without any Company employees present.

15

 
 
Objectives of Compensation Program
 
The Company’s executive compensation program is intended to achieve the objectives of aligning executives’ interests with those of its stockholders by rewarding the executives for long-term growth in the value of the Capital Stock and encouraging them to hold a significant amount of the Company’s equity; paying for performance through both cash and equity-based incentives that, in turn, provide greater rewards for stronger performance of the Company as a whole and the Company’s business units; paying competitively in order to attract and retain senior executives; and creating incentive to maximize the long-term growth of the Company’s business.  To achieve these objectives, the elements of executive compensation are designed to reward past performance and establish incentive for future growth.
 
Elements of Compensation
 
The elements of the Company’s executive compensation program include base salary, annual cash incentive compensation and long-term incentive compensation in the forms of stock option awards, restricted stock awards and awards under the LTIP (in the form of cash and restricted and unrestricted stock awards).  Components of compensation that are available generally to all Company employees, including the Company’s named executive officers, are defined contribution plans and welfare benefit plans (including life insurance, health insurance, dental insurance and long-term disability benefits).  In addition, the Chemed Corporation Excess Benefit Plan No. 1 (as amended, supplemented or otherwise modified as of the date hereof, the “Excess Benefit Plan”), the Chemed Corporation Long Term Care Insurance Plan, the Chemed Corporation Supplemental Pension and Life Insurance Plan (as amended, supplemented or otherwise modified as of the date hereof, the “Supplemental Pension Plan”), the Chemed Corporation Supplemental Severance Benefit Plan (as amended, supplemented or otherwise modified as of the date hereof, the “1986 Severance Plan”) and the Roto-Rooter Deferred Compensation Plan No. 1 (as amended, supplemented or otherwise modified as of the date hereof, the “Deferred Compensation Plan”) are available as components of compensation to executives and other highly compensated individuals.  Base salary, annual cash incentive compensation and pension and welfare benefit plans   are established by the non-employee members of the Board based on the levels that the Compensation Committee and such Board members determine are competitive and are intended to reward executives for current and past performance, while longer-term incentives, such as stock option awards, restricted stock awards and awards under the LTIP, are intended to create incentive for future growth.
 
Executive Compensation Consultant
 
The Compensation Committee’s charter grants it sole authority regarding the appointment, compensation and oversight of the Company’s executive compensation consultant.  The Compensation Committee retained Compensation Strategies, Inc. as its consultant to assist the Compensation Committee with its responsibilities related to the Company’s compensation program for its executives and Board of Directors.  The Compensation Committee directed Compensation Strategies, Inc. to (i) conduct studies of competitive compensation practices and (ii) develop conclusions and recommendations related to the executive compensation plans of the Company for consideration by the Compensation Committee.  Compensation Strategies, Inc. prepared reports and analyses and assisted with (i) an assessment of competitive compensation for non-employee directors, and (ii) a review of base salary, annual incentives and long-term incentive compensation opportunities relative to competitive practices.  Compensation Strategies, Inc. also prepared a report on emerging trends and developments in executive compensation, provided recommendations regarding our executive compensation strategy and performed an assessment of the risks contained in the Company’s incentive compensation plans.
 
The Compensation Committee assessed the independence factors set forth in applicable SEC rules and other facts and circumstances and concluded that the services performed by Compensation Strategies, Inc. did not raise any conflicts of interest.
 
Amount of Each Element of Compensation; Role of Peer Groups; Decisions Concerning Payments
 
The Compensation Committee intends compensation to be linked directly to personal performance and to the Company’s overall results, as well as to the results of the specific business units for which executives are responsible.  The Company’s executive compensation program is focused on rewarding long-term growth.

16

 
 
The Compensation Committee meets as often as necessary in order to carry out its duties.  In 2012, the Compensation Committee met three times.  The Compensation Committee periodically reviews each executive’s total compensation, including base salary, annual cash incentive compensation, stock option awards, restricted stock awards, awards under the LTIP, perquisites and defined contribution plan holdings (including the amounts contributed to such plans by the Company), as well as such executive’s Capital Stock holdings, in recommending or setting, as applicable, each element of compensation.  The Compensation Committee balances the types of compensation for each executive between fixed compensation and performance-based compensation in such a way that less robust Company performance will result in a lower total compensation to the executive.  In 2012, the total compensation, as set forth in the Summary Compensation Table, of all the named executive officers was reduced by the following percents:  Mr. McNamara – (17.3)%; Mr. Williams – (17.3)%; Mr. O’Toole – (20.0)%; Mr. Lee – (22.1)%; and Mr. Tucker – (21.7)%.  For 2012, about 73 percent of Mr. McNamara’s total compensation was performance-based, while the average for the other named executive officers was about 64 percent.  “Performance-based” compensation includes non-equity incentive awards, option awards, and equity incentive and market-based stock awards.
 
In August 2011, the Compensation Committee reviewed a market study prepared by Compensation Strategies, Inc. to determine if the levels and types of compensation paid by the Company to its management are appropriate in comparison with a peer group of companies and in the broader market.  The Compensation Committee was previously relying on a market study of compensation prepared in July 2008.  The companies considered to be part of the peer group in the 2011 study were:
 
Gentiva Health Services, Inc.
Emeritus Corp.
Healthcare Services Group
Healthways Inc.
Skilled Healthcare Group Inc.
Amedisys Inc.
Rollins Inc.
Comfort Systems USA Inc.
Sun Healthcare Group Inc.
Lincare Holdings Inc.
ABM Industries Inc.
Kindred Healthcare Inc.
Five Star Quality Care, Inc.
Rehabcare Group, Inc.
Mednax, Inc.
Sunrise Senior Living, Inc.
Brookdale Senior Living, Inc.
Ecolab Inc.
 
Compensation Strategies, Inc. used regression analysis to normalize the data on annual revenues of the peer companies relative to the Company’s annual revenues to ensure comparability.  An analysis was conducted by these independent compensation consultants in 2011, using 2010 data, of the compensation of 13 company executives (excluding the CEO).  Compensation of the Company executives was compared to “market levels”, defined as executive compensation for the above referenced peer group of 18 publicly-traded companies of similar size to Chemed and broader market information.  A similar analysis was conducted by these independent compensation consultants of 2010 compensation data for the CEO.  After studying the survey, the Compensation Committee determined that the level and balance of the Company’s compensation between fixed and variable incentive compensation were appropriate considering the relative performance of the Company as compared with the peer group.
 
Base Salaries
 
Base salaries of executives are reviewed generally by the Compensation Committee every 14 months, as this results in reduced compensation expense as compared with 12-month review cycles.  In determining the base salaries it recommends to the non-employee members of the Board, the Compensation Committee considers recommendations by certain senior executives of the Company, except with respect to the Chief Executive Officer, for whom the Compensation Committee makes its determination without the input of Company employees.  In so doing, it considers each executive’s then-current base salary and evaluates the responsibilities held by each executive, current economic conditions, and his or her experience and performance.  Additionally, Compensation Strategies, Inc. has periodically reviewed base salaries and provided advice to the Compensation Committee through the peer group studies discussed above.  Positions are compared on the basis of job content and responsibility level to similar positions.  The Compensation Committee recommends base salaries at levels it believes will attract and retain qualified executives.  It believes that the base salaries as finally determined for each of the named executive officers were appropriate and competitive with salaries paid for similar positions by companies in the proxy peer group referred to above and the Company’s industries.  The annual base salary rates of the named executive officers were increased effective January 2012 as follows:  Mr. McNamara – 4.7%; Mr. Williams – 4.7%; Mr. O’Toole – 4.7%; and Mr. Tucker – 4.7%.  Mr. Lee’s base salary was increased 5.0% effective March 1, 2012.

17

 
 
Annual Incentive Compensation
 
Amounts of annual incentive compensation and/or restricted stock incentive compensation are recommended by the Compensation Committee to the non-employee members of the Board.  The Company’s operating results as compared with historical results is the primary consideration in determining annual incentive compensation.  For example, in establishing annual incentive compensation for the executive, management and senior staff personnel, the Compensation Committee reviewed 2012 profit performance as compared with both 2010 and 2011 results as its primary criteria.  Sales and earnings growth, profitability, cash flow, operating performance as compared with budgeted targets, and total stockholder return are also important performance measures in establishing annual incentive compensation amounts.
 
The Company provides its named executive officers, other officers, and other key management employees an opportunity to earn an annual incentive award based on the Company’s, and its operating divisions, financial performance each year.  Diluted earnings per share from continuing operations, excluding non-cash stock option and interest expenses and other items not indicative of ongoing operations (“Adjusted EPS”), is one of the primary metrics considered by the Compensation Committee in determining annual incentive awards.  See the chart on page 3.  The Company discloses Adjusted EPS in its quarterly and annual releases.  Adjusted EPS is used to determine incentive compensation for senior executives of the Company, including the CEO.  The Compensation Committee believes Adjusted Earnings per Share is the most appropriate measurement of financial performance both on an annual and long-term basis, because it reflects the growth of operations and is one of the most well-known measures of overall financial performance, widely used by both financial analysts and the investing public.  The Compensation Committee believes using this measurement better aligns the interests of incentive plan participants with those of the Company’s stockholders.
 
The Compensation Committee uses a formula of two times the rate of growth/decline in EPS minus 10%, applied to prior year actual payouts, to determine the annual incentive compensation for senior executives.  The Compensation Committee has no discretion to adjust incentive compensation for the named executive officers resulting from application of this formula.  The Compensation Committee’s formula is designed to leverage the effect of Adjusted EPS performance on annual incentive compensation potential.  Relatively lower rates of Adjusted EPS growth result in even lower growth rates in annual incentive compensation, while growth rates of Adjusted EPS in excess of 10% yield incentive increases in excess of the Adjusted EPS growth rate.  The Compensation Committee’s formula also works to leverage the reduction in incentives in periods of performance decline.  For example, a decline in Adjusted EPS of 5% would result in a 20% reduction in incentives for named executive officers [(2 X -5%) -10%].  The Compensation Committee believes this structure and the leveraging effect of the formula as constructed provides a significant incentive for consistently achieving superior operating performance.
 
Actual Adjusted EPS for 2012 was $5.20 per share, an increase of approximately 7.9% over Adjusted EPS for 2011 of $4.82 per share.  Under the Compensation Committee’s formula, the increase in bonuses for 2012 was 5.8%, calculated as [(2 X 7.9%) -10%].  The detailed calculation of annual incentive compensation for the named executive officers is shown in the table below.  In the cases of Messrs. O’Toole and Lee, the formula is applied 2/3 to their respective unit performance, and 1/3 to the performance of Chemed in total, in recognition of their roles as business unit heads and executive officers.

18

 

Long-Term Incentives
 
The Compensation Committee grants long-term incentive compensation pursuant to the Stock Incentive Plans and the LTIP.  While long-term incentive compensation may be paid under the Stock Incentive Plans in the form of stock option awards and restricted or fully vested stock awards, currently all of the long-term incentive awards granted pursuant to such plans are in the form of stock option or restricted stock awards.  LTIP awards may be made in the form of cash and restricted and fully vested stock awards; however, currently only restricted and fully vested awards are granted from the Stock Incentive Plans under the LTIP.  In granting long-term incentives in the form of stock option awards, restricted stock awards and unrestricted LTIP share awards, the Compensation Committee considers as recipients employees who have demonstrated capacity for contributing to the Company’s goals.  In all cases, the long-term equity awards are intended to encourage employees to act as owners of the business, further aligning their interests with those of stockholders.

19

 
 
The Compensation Committee grants stock option awards with an exercise price at no less than 100% of fair market value of Capital Stock on the date granted.  Historically, the vesting schedule of stock option awards has varied from immediately exercisable to four annual installments commencing six months after the date an award was granted.  Since 2006, stock option awards vest ratably over three years, thus providing value to the Company’s employees only if the share price increases after the date such awards were granted and the employees remain employed for a significant period of time.  Restricted stock awards generally cliff vest on the fourth anniversary of the date granted, again with the intent of retaining employees for a significant period of time, and carry with them voting and dividend rights.  The Compensation Committee believes the payment of long-term incentive compensation in the form of restricted stock awards promotes and encourages long-term retention and service for the Company and better aligns the interests of the named executive officers with those of the Company’s stockholders through increased share ownership, promoting improved financial performance, and increased stockholder value.  The Compensation Committee believes time-based awards encourage retention of executives.
 
Beginning in 2009, annual stock option awards were granted in February to allow the Compensation Committee to consider long-term incentive awards at the same time that it considers annual incentive awards.  Beginning in 2013 such awards will be considered in November, to allow consideration of the Company’s performance during that year.  Both long-term incentive awards and annual incentive awards are granted based on the Compensation Committee’s evaluation of an employee’s performance during the prior year.  The stock option and stock awards are not granted so as to “time” them before the release of material nonpublic information that is likely to result in an increase in share price (“spring-loading”) or delay them until after the release of material nonpublic information that is likely to result in a decrease in share price (“bullet-dodging”).  The Company does not reprice stock option awards or replace them if the share price declines after the date such stock option awards were granted.
 
In May 2002, the stockholders of the Company approved the adoption of the LTIP, which covers officers and key employees of the Company.  It was intended to replace the Company’s restricted stock program under which restricted stock awards were granted which vested over a period of four to seven years.  The LTIP is administered by the Compensation Committee.
 
Since 2002, the Compensation Committee has adopted LTIP guidelines that cover the granting of awards based on operating performance and attainment of target share prices.  Each period for establishing a set of targets for operating performance and share prices is called a Plan Period, and Plan Periods overlap due to the staggered timing of the set targets.  The LTIP provides for grants of cash awards and restricted and fully vested stock awards based on the achievement of certain targets.  However, currently only restricted and fully vested stock awards are granted, and they are granted in the following circumstances:
 
-	80,000 shares of Capital Stock in the aggregate are to be granted to the participants in the LTIP if the Company’s cumulative adjusted EBITDA reaches $825 million between January 1, 2010 and December 31, 2013.  The Company discloses adjusted EBITDA in its quarterly and annual earnings releases.	
 	 	
-	75,000 shares of Capital Stock in the aggregate are to be granted to the participants in the LTIP if the closing share price reaches the following targets during any 30 trading days out of any 60-day trading period between February 18, 2011 and February 18, 2014:

-	25,000 shares of Capital Stock at $79.00;	
-	25,000 shares of Capital Stock at $85.00;	
-	25,000 shares of Capital Stock at $90.00.	

The Compensation Committee previously had discretion with regard to the granting of an additional 16,900 shares of Capital Stock in the aggregate to the participants in the LTIP.  During 2012, such discretionary pool was eliminated.

20

 
 
Previously, if an operating performance or a share price target was met, the Compensation Committee determined the number of stock awards to be granted to each participant, other than the Chief Executive Officer, based on the recommendations of certain senior executives of the Company.  The number of stock awards to be granted to the Chief Executive Officer was determined by the Compensation Committee without the input of Company employees.  Beginning in 2012, the Compensation Committee predetermined the amount of vested share awards to the plan participants in the event the EBITDA or stock price targets are achieved.  The amounts to be awarded to the named executive officers are as follows:
 
 	Stock Price Targets	 	 	
 	 	 	 	 	 	 	 	
 	$79	 	$85	 	$90	 	EBITDA	
K. J. McNamara	4,255 Shares	 	4,255 Shares	 	4,255 Shares	 	13,625 Shares	
D. P. Williams	2,190	 	2,190	 	2,190	 	7,000	
T. S. O'Toole	2,435	 	2,435	 	2,435	 	7,800	
S. S. Lee	1,215	 	1,215	 	1,215	 	3,900	
A. V. Tucker, Jr.	1,095	 	1,095	 	1,095	 	3,500	
 
As none of the performance targets were achieved, no LTIP awards were earned during 2012.
 
Perquisites
 
The Company’s executive compensation program offers perquisites that are commonly available to senior executives, the nature and amounts of which are detailed in the All Other Compensation Table.
 
Retirement Benefits
 
The Company maintains the Retirement Plan, a tax-qualified defined contribution plan, for the benefit of its employees, including the named executive officers.  The Retirement Plan permits employees to contribute a portion of their pay to the plan on a pre-tax basis.  The Company also provides a matching contribution to employees who contribute to the plan. The named executive officers participate in the Retirement Plan within the limits imposed by the Internal Revenue Code (the “Code”) and the Employee Retirement Income Security Act (“ERISA”).
 
The Company also maintains the Excess Benefit Plan and the Deferred Compensation Plan, which are non-qualified supplemental savings plans for key employees, including the named executive officers, whose participation in the Retirement Plan is limited by the Code and ERISA.  Messrs. McNamara, Williams, O’Toole and Tucker participate in the Excess Benefit Plan, and Mr. Lee participates in the Deferred Compensation Plan.  These plans allow participants to defer up to 50% of their base salary and up to 85% of their annual cash incentive compensation and income from stock awards and provide a matching contribution from the Company.  Participants select mutual funds as investments, and amounts deferred and credited to participant accounts under the plans are credited with earnings or losses depending on the performance of the selected mutual funds.  Participants may receive the amounts credited to their accounts at retirement, termination of employment or on a specific date following termination or retirement and may also elect to receive a portion of each year’s deferral and earnings on a specific date prior to retirement or termination of employment.  Participants may receive such amounts in a lump-sum payment or in installment payments.
 
Each of the named executive officers also participates in the Supplemental Pension Plan, which provides certain key employees with a supplemental pension and optional life insurance benefit.  The Company accrues a fixed monthly contribution to each participant’s account under this plan, and participants’ accounts are credited with monthly earnings based on an annual interest rate.  Participants have the option to use a portion of this Company contribution to purchase supplemental term life insurance.  Mr. Tucker also participates in the 1986 Severance Plan, which is an unfunded defined contribution plan in which Mr. Tucker’s account is credited with certain Company contributions that will pay out upon his death or termination of employment.

21

 
 
Tax Considerations
 
U.S. federal income tax law prohibits the Company from taking a deduction for compensation paid to its covered executive officers over $1,000,000 per executive per year, but exempts certain performance-based compensation.  The Compensation Committee considers tax regulations in structuring compensation arrangements to achieve deductibility, except where outweighed by the need for flexibility, or as the Company otherwise determines is in the best interests of the Company and its stockholders.
 
Employment Agreements; Severance Payments; Change in Control
 
The Company has employment agreements with three of its named executive officers:  Messrs. McNamara, Williams and O’Toole.  On May 3, 2008, Mr. McNamara entered into a two-year employment agreement, which automatically renews every May 3 beginning May 3, 2010 for an additional one-year term unless either party provides 30 days’ prior written notice of non-renewal.  Mr. McNamara’s employment agreement provides for a lump-sum severance payment, in the event of termination without cause, equal to five times his then-current base salary plus a pro-rated portion of his average annual incentive compensation for the then-past three full fiscal years.  In the event of termination without cause, he also would be entitled to continue to participate in the Company’s welfare benefit plans for 24 months following termination at the then-current rate of contribution.  The employment agreements with Messrs. Williams and O’Toole, entered into in December 2006 and May 2007, respectively, contain the same terms as outlined above for Mr. McNamara, except that each of Messrs. Williams and O’Toole would be entitled to a lump-sum severance payment equal to two and a half times his then-current base salary and continued participation in the Company’s welfare benefit plans for 18 months following termination at the then-current rate of contribution.  Such severance payments and benefits are conditioned upon execution of a general release of claims in favor of the Company, nondisclosure and, for Mr. McNamara, two-year non-compete and non-solicitation covenants and, for Messrs.  Williams and O’Toole, one-year non-compete and non-solicitation covenants.  If these payments were subject to the excise taxes imposed by Section 409A of the Code, Messrs. McNamara, Williams and O’Toole would be entitled to gross-up payments.  The Company does not intend to enter into future employment agreements that provide for excise tax gross-ups.
 
For a termination due to death, disability or retirement, each of Messrs. McNamara, Williams and O’Toole would be entitled under his employment agreement to a lump-sum payment equal to the pro-rated portion of the average of his annual incentive compensation for the then-past three full fiscal years.  Such severance payments under each employment agreement for a termination due to disability or retirement are conditioned upon execution of a general release of claims in favor of the Company and a nondisclosure covenant.
 
In 2006, the Board of Directors adopted the Chemed Corporation Senior Executive Severance Policy (as amended, supplemented or otherwise modified as of the date hereof, the “Senior Executive Severance Policy”) and the Chemed Corporation Change in Control Severance Plan (as amended, supplemented or otherwise modified as of the date hereof, the “Change in Control Plan”), which were intended to replace most of the existing employment agreements entered into by the Company.  Accordingly, rather than enter into new employment agreements with 12 Company executives, including Messrs. Lee and Tucker, whose employment agreements had expired or were about to expire, such executives’ severance and change in control benefits are now governed by the Senior Executive Severance Policy and the Change in Control Plan.  Messrs. McNamara, Williams and O’Toole are not covered by the Senior Executive Severance Policy, but are covered by the Change in Control Plan.  However, in the event of a change in control of the Company, Messrs. McNamara, Williams and O’Toole would not receive benefits under both their employment agreements and the Change in Control Plan.  With the shift from individual employment agreements to general severance and change in control plans, the Compensation Committee intended to reduce total payouts to executives upon termination and move the Company’s executive severance arrangements more in line with market practices.
 
Under the Senior Executive Severance Policy, if an executive is terminated without cause, he or she would be entitled to a lump-sum payment equal to one and a half times his or her then-current base salary and a pro-rated portion of his or her average annual incentive compensation for the then-past three full fiscal years.  Such executive would also be entitled to continued participation in the Company’s welfare benefit plans for one year following termination of employment at the then-current rate of contribution.  Severance payments and benefits under the Senior Executive Severance Policy are conditioned upon execution of a general release of claims in favor of the Company.  Additionally, for a termination without cause or due to disability or retirement, such severance payments and benefits are conditioned upon nondisclosure and one-year non-compete and non-solicitation covenants.  If payments under the Senior Executive Severance Policy were subject to the excise taxes imposed by Section 409A of the Code, participants would be entitled to gross-up payments.  In the event of a change in control of the Company, participants in the Senior Executive Severance Policy would not receive benefits under both the Senior Executive Severance Policy and the Change in Control Plan.   For a termination due to death, disability or retirement, each of the participants in the Senior Executive Severance Policy would be entitled to a lump-sum payment equal to the pro-rated portion of the average of his or her annual incentive compensation for the then-past three full fiscal years.

22

 
 
The Change in Control Plan, described in additional detail under the “Change in Control of the Company” heading below, provides for severance payments and benefits in the event of a change in control of the Company followed within two years by an executive’s termination of employment either without cause or for good reason (“double trigger”). Payments under the Change in Control Plan are triggered by:
 
 	a)	termination of employment by the Company without cause; or	

 	b)	termination of employment by the employee within 90 days of an event giving him or her good reason to so terminate.	
 
The Change in Control Plan would provide for payments equal to three times the sum of (a) the highest base salary during the 120-day period prior to the change in control or any time following the change in control and (b) the average annual incentive compensation for the then-past three full fiscal years to Messrs. McNamara, Williams and O’Toole, and two times the sum of (a) the highest base salary during the 120-day period prior to the change in control or any time following the change in control and (b) the average annual incentive compensation for the then-past three full fiscal years to the other participants, all paid in cash in a lump sum within 10 days following termination.  If the termination were to take place in a fiscal year other than the fiscal year during which the change in control occurred, each participant would also receive a pro-rated portion of his or her three-year average annual incentive compensation.  Participants would also receive benefits under the Company’s welfare benefit plans for a period of three (for Messrs. McNamara, Williams and O’Toole) or two years; a lump-sum cash payment within 10 days following termination in the amount of employer contributions to defined contribution plans; perquisites for a period of three (for Messrs. McNamara, Williams and O’Toole) or two years; and outplacement assistance up to $25,000.  Regardless of whether a participant is terminated and in addition to the severance benefits set forth above, upon a change in control, each participant in the Change in Control Plan would receive, within 10 days following the change in control, a lump-sum cash payment equal to the average of the participant’s annual incentive compensation for the then-past three full fiscal years, all unvested portions of stock option and restricted stock awards would vest in full and the Compensation Committee would distribute any shares of Capital Stock then unallocated under the Company’s equity-based plans (“single-trigger” payments).  Payments under the Change in Control Plan, including single-trigger payments, are conditioned on execution of a general release of claims in favor of the Company.  If payments under the Change in Control Plan were subject to taxes imposed by Sections 4999 or 409A of the Code, participants would be entitled to gross-up payments.
 
Capital Stock Ownership Guidelines
 
Executive ownership of Capital Stock reflects an alignment of the interests of the Company’s executives and directors with those of its stockholders.  All the Company’s non-employee directors, Vice Presidents, Senior Vice Presidents, Executive Vice Presidents, Business Unit Presidents and its Chief Executive Officer are required to acquire and retain stock ownership in the Company, measured as a meaningful level of a multiple of their base salary or board retainer in shares of Capital Stock.
 
The Chief Executive Officer’s required Capital Stock ownership multiple is five times base salary; for the Chief Financial Officer, Executive Vice Presidents and Business Unit Presidents, four times; for Senior Vice Presidents, three times; and for Vice Presidents, two times base salary.  Time-based restricted stock awards count towards Capital Stock ownership goals.  Non-employee directors are required to retain five times their annual board retainer, which is $45,000, resulting in required holdings of $225,000 in 2012.  These guidelines are administered by the Compensation Committee.  Mr. McNamara currently holds shares of Capital Stock with a market value of approximately 15 times his current base salary.  All named executive officers, directors, and other executives have met their Capital Stock ownership guidelines or are pursuing plans that will permit them to achieve them within the time frame allotted by the guidelines.  

23

 
 
Compensation Committee Report
 
The Compensation Committee has reviewed and discussed the Compensation Discussion and Analysis set forth above with the Company’s management.  Based on these reviews and discussions the Compensation Committee recommended to the Board of Directors that the Compensation Discussion and Analysis be included in the Company’s 2012 Annual Report on Form 10-K and the Company’s 2013 Proxy Statement:
 
George J. Walsh III, Chairman
Walter L. Krebs
Andrea R. Lindell
Frank E. Wood

24

 

Summary Compensation Table
 
The following table shows the compensation paid to the Chief Executive Officer, the Chief Financial Officer and the three other most highly compensated executive officers of the Company in 2010, 2011 and 2012 for all services rendered in all capacities to the Company and its subsidiaries:
 
SUMMARY COMPENSATION TABLE

 
25

 
 
ALL OTHER COMPENSATION TABLE
 
The table below describes each component of the All Other Compensation column in the Summary Compensation Table:

 
26

 
 
Grants of Plan-Based Awards
 
The following table shows stock option and stock awards granted in 2012 to the named executive officers in the Summary Compensation Table pursuant to the Stock Incentive Plans and the Company’s LTIP.

Narrative to Summary Compensation Table and Grants of Plan-Based Awards Table

The following is a description of material factors necessary to understand the information disclosed in the Summary Compensation Table, the All Other Compensation Table and the Grants of Plan-Based Awards in 2012 Table.  This discussion is meant to supplement the information contained in the Compensation Discussion and Analysis.

“Performance-Based” Compensation in Proportion to Total Compensation

In 2012, the named executive officers’ “performance-based” compensation, including non-equity incentive awards, option awards, and equity incentive and market-based stock awards, represented the following approximate percentages of their total compensation:  Mr. McNamara – 72.6%; Mr. Williams – 68.4%; Mr. O’Toole – 61.5%; Mr. Lee – 56.4%; and Mr. Tucker – 67.3%.  The Compensation Committee believes that this mix of compensation balances the objectives of rewarding recent results and motivating long-term performance.  Additionally, in determining the appropriate combination of compensation, the Compensation Committee places an emphasis on stock options and stock awards in order to closely align the executives’ interests with those of the Company’s stockholders and reward stronger performance of the Company.

27

 

Employment Agreements
 
The Company has employment agreements with three of its named executive officers: Messrs. McNamara, Williams and O’Toole. On May 3, 2008, Mr. McNamara entered into a two-year employment agreement, which provided for his continued employment as a senior executive officer of the Company through May 2, 2010.  The agreement automatically renews on each subsequent May 3 for a one-year term unless either party provides 30 days’ prior written notice of non-renewal.  The agreement provides for a base salary of $700,000 or such higher amount as the Board of Directors may determine.  Mr. McNamara’s current base salary is $841,250.  Mr. McNamara’s employment agreement provides for a lump-sum severance payment, in the event of termination without cause, equal to five times his then-current base salary plus a pro-rated portion of his average annual incentive compensation for the then-past three full fiscal years. He also will be entitled to continue to participate in the Company’s welfare benefit plans for 24 months following termination at the then-current rate of contribution. Such severance payments and benefits are conditioned upon execution of a general release of claims in favor of the Company, nondisclosure and two-year non-compete and non-solicitation covenants. If such payments were subject to the excise taxes imposed by Section 409A of the Code, Mr. McNamara would be entitled to gross-up payments.
 
Mr. Williams’ employment agreement, entered into on December 1, 2006, provided for his employment as a senior financial executive through November 30, 2008, after which time the term of the agreement was automatically extended by one year and will be further extended by one year on each subsequent December 1 unless either party provides 30 days’ prior written notice of non-renewal. The agreement provides for a base salary of $313,500 or such higher amount as the Board of Directors may determine.  Mr. Williams’ current base salary is $443,400.  Mr. O’Toole’s employment agreement, entered into on May 6, 2007, provides for his employment as a senior executive of the Company through May 5, 2009, after which time the term of the agreement was automatically extended by one year and will be further extended by one year on each subsequent May 6 unless either party provides 30 days’ prior written notice of non-renewal.  Mr. O’Toole’s agreement provides for a base salary of $504,500 or such higher amount as the Board of Directors may determine. Mr. O’Toole’s current base salary is $610,500.
 
Each of Messrs. Williams’ and O’Toole’s agreements is identical in all material respects to Mr. McNamara’s, except if he were terminated without cause, he would (a) receive a lump-sum severance payment equal to two and a half times his then-current base salary plus a pro-rated portion of his average annual incentive compensation for the then-past three full fiscal years and (b) be entitled to continue to participate in the Company’s welfare benefit plans for 18 months following termination at the then-current rate of contribution.  Such severance payments and benefits for Messrs. Williams and O’Toole are conditioned upon execution of a general release of claims in favor of the Company, nondisclosure and one-year non-compete and non-solicitation covenants.  If such payments were subject to the excise taxes imposed by Section 409A of the Code, Messrs. Williams and O’Toole would be entitled to gross-up payments.
 
The definition of “cause” under each of the employment agreements is set forth below under the heading “Termination Without Cause Prior to and Not in Connection With a Change in Control of the Company; Termination Due to Death, Disability or Retirement - Employment Agreements.”
 
For a termination due to death, disability or retirement, each of Messrs. McNamara, Williams and O’Toole would be entitled under his employment agreement to a lump-sum payment equal to the pro-rated portion of the average of his annual incentive compensation for the then-past three full fiscal years.  Such severance payments under each employment agreement for a termination due to disability or retirement are conditioned upon execution of a general release of claims in favor of the Company and a nondisclosure covenant.
 
A more detailed discussion of amounts that would be payable to Messrs. McNamara, Williams and O’Toole upon termination is set forth below under the heading “Potential Payments to Executives Upon Termination or Change in Control.”

28

 
 
Annual Cash Incentives
 
Annual cash incentive compensation is granted by the Compensation Committee, subject to approval by the Board.  For 2012, annual cash incentive compensation was awarded to each of the named executive officers.  The amount of the annual cash incentive compensation awards are set forth in the “Non Equity Incentive Award” column of the Summary Compensation Table.  A more detailed discussion of the criteria that the Compensation Committee considered when recommending the amount of the 2012 cash incentive compensation is set forth in the Compensation Discussion and Analysis.
 
Stock Incentive Plans
 
The Company has four Stock Incentive Plans under which stock option awards to purchase shares of Capital Stock and awards of restricted and fully vested stock may be granted for a period of ten years to key employees:  the 2004 Incentive Plan, the 2006 Incentive Plan and the 2010 Incentive Plan.  The Company currently grants stock option and restricted stock awards annually to key employees, including the named executive officers, pursuant to the Stock Incentive Plans.
 
All stock option awards granted under these plans provide for a purchase price equal to the fair market value of the Capital Stock at the date granted. Fair market value is defined as the mean between   the high and low sales prices of a share of Capital Stock on the New York Stock Exchange.  Stock option awards granted under the Stock Incentive Plans are non-qualified and, when vested, are exercisable for fully vested shares of Capital Stock.  Stock option awards granted in 2010, 2011 and 2012 will become exercisable in three equal installments on each of the first three anniversaries of the date such awards were granted.  Vested stock option awards remain exercisable for three months following termination of the holder’s employment, if the Compensation Committee so specifically consents, except for termination due to death, incapacity or retirement, in which case vested stock option awards remain exercisable for 15 months following termination.  Unvested stock option awards are forfeited upon termination of employment for any reason other than death, disability or retirement, in which case unvested option awards are forfeited three months after termination.  All unvested stock option awards held by employees will accelerate and vest upon a change in control of the Company.
 
Restricted stock awards may not be sold or otherwise transferred until they vest.  If the recipient’s employment terminates due to death, disability or termination without cause, or if there is a change in control of the Company, the restrictions on transfer terminate.  Upon the holder’s retirement, the restrictions will lapse as to a fraction of the restricted stock equal to the length of time, in years, from the date such awards were granted to the date of the holder’s retirement over the total number of years over which the award would have vested.  Otherwise, restricted stock awards are forfeited upon the holder’s termination of employment.  Holders receive dividends on restricted stock and are entitled to vote such stock, whether or not it has vested.
 
Long-Term Incentive Plan
 
In 2002, the stockholders approved the LTIP, which provides for grants of cash awards and restricted and fully vested stock awards to officers and key employees of the Company.  However, currently only restricted and fully vested stock awards are granted under the LTIP.  Based on guidelines established by the Compensation Committee, the LTIP permits awards upon the attainment of certain operating performance goals and target share prices.  No awards were earned under the LTIP in 2012.  A more detailed discussion of the LTIP can be found in the Compensation Discussion and Analysis.
 
Other Plans
 
The named executive officers participate in various plans that are generally available to the employees of the Company, including the Retirement Plan, which is a tax-qualified defined contribution plan, and the Company’s welfare benefit plans.  In addition, the Company has several non-qualified supplemental savings plans for key employees (including each of the named executive officers) whose participation in the Retirement Plan is limited by rules imposed by the Code and ERISA. These non-qualified supplemental savings plans are discussed in greater detail in the narrative that follows the Nonqualified Deferred Compensation Table.  The contributions of the Company which were credited into these plans in 2012 on behalf of each of the named executive officers are set forth in the Nonqualified Deferred Compensation Table.

29

 
 
Eligible employees, including each of the named executive officers, also participate in the Supplemental Pension Plan.  Mr. Tucker also accrues a benefit under the 1986 Severance Plan. The Supplemental Pension Plan and 1986 Severance Plan are supplemental defined contribution plans and are discussed in greater detail in the narrative that follows the Nonqualified Deferred Compensation Table.  Each named executive officer’s accrual of benefits under these plans for 2012 is set forth in the Nonqualified Deferred Compensation Table.
 
Outstanding Equity Awards at Year End
 
The following table shows outstanding equity awards at 2012 year end held by the named executive officers in the Summary Compensation Table:
 
OUTSTANDING EQUITY AWARDS AT YEAR END 2012

Number of Market Value Securities Of Shares Underlying or Units of Unexercised Option Stock Options Exercise Option That Have Not (#) Price Expiration Vested (j) Name Exercisable ($) Date ($) K.J. McNamara 70,000 - 51.76 6/28/2016 - - 100,000 - 67.96 5/21/2017 - - 40,000 - 44.02 2/19/2019 - - 66,666 33,334 (a) 52.76 2/18/2020 - - 33,333 66,667 (b) 65.17 2/18/2021 - - - 86,000 (c) 63.36 2/17/2022 - - - - - n.a. 11,359 (d) 779,114 - - - n.a. 11,846 (e) 812,517 - - - n.a. 8,700 (f) 596,733 - - - n.a. 9,207 (f) 631,508 - - - n.a. 9,470 (g) 649,547 - - - n.a. 12,765 (h) 875,551 - - - n.a. 13,625 (i) 934,539 D.P. Williams 26,250 - 51.76 6/28/2016 - - 50,000 - 67.96 5/21/2017 - - 35,000 - 44.02 2/19/2019 - - 23,333 11,667 (a) 52.76 2/18/2020 - - 11,666 23,334 (b) 65.17 2/18/2021 - - 30,000 (c) 63.36 2/17/2022 - - - - - n.a. 4,680 (d) 321,001 - - - n.a. 4,928 (e) 338,012 - - - n.a. 4,600 (f) 315,514 - - - n.a. 3,790 (f) 259,956 - - - n.a. 3,898 (g) 267,364 - - - n.a. 6,570 (h) 450,636 - - - n.a. 7,000 (i) 480,130 T.S. O'Toole 20,000 - 67.96 5/21/2017 - - 23,333 11,667 52.76 2/18/2020 - - 11,666 23,334 (a) 65.17 2/18/2021 - - - 25,000 (c) 63.36 2/17/2022 - - - - - n.a. 5,997 (d) 411,334 - - - n.a. 5,497 (e) 377,039 - - - n.a. 4,600 (f) 315,514 - - - n.a. 3,790 (f) 259,956 - - - n.a. 3,709 (g) 254,400 - - - n.a. 7,305 (h) 501,050 - - - n.a. 7,800 (i) 535,002 Unexercisable Number of Securities Underlying Unexercised Options (#) Option Awards Stock Awards Not Vested (#) Number of Shares or Units of Stock That Have
 
30

 

Number of Market Value Securities Of Shares Underlying or Units of Unexercised Option Stock Options Exercise Option That Have Not (#) Price Expiration Vested (j) Name Exercisable ($) Date ($) S.S. Lee 34,000 - 21.78 5/17/2014 - - 17,000 - 38.13 3/11/2015 - - 17,500 - 51.76 6/28/2016 - - 19,000 - 67.96 5/21/2017 - - 19,000 - 33.75 5/19/2018 - - 19,000 - 44.02 2/19/2019 - - 12,666 6,334 (a) 52.76 2/18/2020 - - 6,333 12,667 (b) 65.17 2/18/2021 - - - 17,500 (c) 63.36 2/17/2022 - - - - - n.a. 1,817 (d) 124,628 - - - n.a. 1,516 (e) 103,982 - - - n.a. 2,750 (f) 188,623 - - - n.a. 967 (f) 66,327 - - - n.a. 1,105 (g) 75,792 - - - n.a. 3,645 (h) 250,011 - - - n.a. 3,900 (i) 267,501 A.V. Tucker, Jr. 14,000 - 51.76 6/28/2016 - - 18,000 - 67.96 5/21/2017 - - 12,000 6,000 (a) 52.76 2/18/2020 - - 6,000 12,000 (b) 65.17 2/18/2021 - - - 15,000 (c) 63.36 2/17/2022 - - - - n.a. 2,408 (d) 165,165 - - n.a. 2,274 (e) 155,974 - - n.a. 2,300 (f) 157,757 - - n.a. 1,749 (f) 119,964 - - - n.a. 1,799 (g) 123,393 - - - n.a. 3,285 (h) 225,318 - - - n.a. 3,500 (i) 240,065 (a) All of the unvested stock option award will vest on February 18, 2013. (b) Half of the remaining stock option award will vest on February 18, 2013 and the remainder on February 18, 2014. (c) One third of the stock option award will vest on February 17, 2013, one third on February 17, 2014 and the remainder on February 17, 2015. (d) Award will vest in full on February 19, 2013. (e) Award will vest in full on February 18, 2014. (f) Award will vest in full on February 18, 2015. (g) Award will vest in full on February 17, 2016. (h) Award vests upon attainment of certain stock price targets on or prior to February 18, 2014. (i) Award vests upon attainment of specified earnings target for the four-year period ending December 31, 2013. (j) Amounts are based on the $68.59 closing price of the Capital Stock on December 31, 2012. Unexercisable Number of Securities Underlying Unexercised Options (#) Option Awards Stock Awards Not Vested (#) Number of Shares or Units of Stock That Have
 
31

 
 
Stock Option Award Exercises and Stock Awards Vested
 
The table below shows information concerning the exercise of stock option awards and vesting of restricted stock awards during 2012 for the named executive officers in the Summary Compensation Table:
 
OPTION EXERCISES AND STOCK VESTED IN 2012

Nonqualified Defined Contribution and other Nonqualified Deferred Compensation Plans
 
The table below shows information concerning compensation deferred under the Excess Benefit Plan, the Deferred Compensation Plan, the 1986 Severance Plan and the Supplemental Pension Plan during 2012 by each of the named executive officers in the Summary Compensation Table:
 
NONQUALIFIED DEFERRED COMPENSATION IN 2012

Executive Registrant Aggregate Aggregate Contributions Contributions Earnings Balance in Last FY in Last FY in Last FY at Last FYE Name ($) ($)(a) ($) ($) K.J. McNamara Excess Benefit Plan 119,475 $ 382,190 $ 1,127,511 $ 7,687,046 $ Supplemental Pension and Life Insurance Plan (b) - 26,356 19,950 306,742 D.P. Williams Excess Benefit Plan 41,529 148,055 226,278 1,816,393 Supplemental Pension and Life Insurance Plan (b) - 12,185 9,224 141,814 T.S. O'Toole Excess Benefit Plan 65,487 173,436 302,522 3,494,124 Supplemental Pension and Life Insurance Plan (b) 23,218 17,575 270,221 S.S. Lee Roto-Rooter Deferred Compensation Plan - 80,300 429,526 3,086,063 Supplemental Pension and Life Insurance Plan (b) - 11,965 9,057 139,255 A.V. Tucker, Jr. Excess Benefit Plan - 50,363 182,084 1,482,475 Supplemental Pension and Life Insurance Plan (b) - 7,003 5,301 81,504 1986 Severance Plan (b) - - 314 4,768
(a)	Amounts reported in All Other Compensation Table for 2012.	

(b)	To the extent that earnings reflected herein exceeded 120% of the long-term applicable federal rate as in effect in July 2012, such earnings are reported for 2012 in the All Other Compensation Table.	

32

 
 
The Excess Benefit Plan and the Deferred Compensation Plan
 
Each of the named executive officers participates in either the Excess Benefit Plan or the Deferred Compensation Plan (collectively, the “Plans”).  The Plans are non-qualified supplemental savings plans that allow participants to defer up to 50% of their base salary and up to 85% of their annual cash incentive compensation and stock award income. The Plans also provide the participants with Company matching contributions which would have been received in the tax-qualified Retirement Plan had the participant’s participation in the Retirement Plan not been limited by rules imposed under the Code and ERISA. The Plans offer only mutual funds as investment options for participant contributions.  Participants select the mutual funds as investments, and amounts deferred and credited to participant accounts under the Plans are credited with earnings or losses depending on the performance of the selected mutual funds.  Participants can change their investment options for both future deferrals and current account balances at any time. The earnings credited to the accounts of participants are equal to the actual earnings from the mutual funds in which the participants elect to invest.
 
The table below shows the funds available under the Excess Benefit Plan and the Roto-Rooter Deferred Compensation Plan and their annual rates of return for the calendar year ended December 31, 2012, as reported by the administrator of the Plans.

Prior to making deferrals in the Plans, participants must specify the date and manner in which they wish to receive their distribution from the Plans.  Participants may receive the amounts credited to their accounts at retirement, termination of employment or on a specific date following termination or retirement. Participants must also elect whether to receive distributions in a lump sum or in installment payments. Participants may elect to receive some or all of each year’s deferral and related earnings on a specific date prior to retirement or termination of employment (“In-Service Distribution”). In order to satisfy the requirements of Section 409A of the Code, certain “key employees” may not receive a distribution from the Plans until six months following a separation from service. In-Service Distributions are not subject to the six-month delay.
 
Messrs. McNamara, Williams, O’Toole and Tucker received Company contributions in the Excess Benefit Plan for the plan year 2012 in the amounts set forth in the Nonqualified Deferred Compensation Table.  Also as set forth in the Nonqualified Deferred Compensation Table, Messrs. McNamara, Williams, and O’Toole have each elected to defer a portion of his 2012 compensation to the Excess Benefit Plan and have also received Company contributions in such plan.
 
Supplemental Pension Plan
 
The Supplemental Pension Plan is an unfunded defined contribution plan that provides certain key employees with a supplemental pension and an optional life insurance benefit. Participants’ accounts are credited with a fixed monthly Company contribution. Participants have the option to use a portion of this Company contribution to purchase supplemental term life insurance. The Supplemental Pension Plan does not allow for employee contributions or deferrals. The participants’ accounts are credited with monthly earnings based on an annual interest rate. This interest rate is subject to change once a year and is based on then-prevailing interest rates. Currently this interest rate is 7%. All of the named executive officers are participants in the Supplemental Pension Plan.

33

 
 
1986 Severance Plan
 
The 1986 Severance Plan was established in connection with the Company’s 1986 elimination of its defined benefit retirement plan and adoption of a defined contribution plan. It is an unfunded defined contribution plan in which the participants’ accounts are credited with certain Company contributions.  Mr. Tucker is the only named executive officer who participates in the 1986 Severance Plan.
 
Potential Payment to Executives Upon Termination or Change in Control
 
The following table represents the amounts of compensation that would be due to each of the named executive officers upon each of the listed scenarios pursuant to the Company’s plans and agreements, as if such event had occurred on December 31, 2012.  The amounts shown are estimates of the amounts that would be payable in each circumstance, and the actual amounts payable will only be determined upon the actual occurrence of such event.

34

 

K.J. D.P. T.S. S.S. A.V. McNamara Williams O'Toole Lee Tucker, Jr. Termination without Cause Severence payment (a)(b) 4,206,250 $ 1,108,500 $ 1,526,250 $ 469,500 $ 327,750 $ Pro-rated annual incentive compensation (a) 2,041,680 758,824 695,673 280,839 272,581 Welfare benefit continuation (c) 31,678 27,980 19,620 20,952 13,944 Accleration of restricted stock awards (d) 3,469,419 1,501,847 1,618,244 559,351 722,253 Total 9,749,027 $ 3,397,151 $ 3,859,787 $ 1,330,642 $ 1,336,528 $ Involuntary Termination for Cause or Voluntary Termination Severence payment - - - - - Welfare benefit continuation - - - - - Total - - - - - Termination due to Death or Disability Pro-rated annual incentive compensation (a) 2,041,680 $ 758,824 $ 695,673 $ 280,839 $ 272,581 $ Welfare benefit continuation - - - - - Acceleration of restricted stock awards (d) 3,469,419 1,501,847 1,618,244 559,351 722,253 Total 5,511,099 $ 2,260,671 $ 2,313,917 $ 840,190 $ 994,834 $ Termination due to Retirement Pro-rated annual incentive compensation (a) 2,041,680 $ 758,824 $ 695,673 $ 280,839 $ 272,581 $ Welfare benefit continuation - - - - - Acceleration of restricted stock awards (d) 1,297,654 553,658 640,974 209,268 271,273 Total 3,339,334 $ 1,312,482 $ 1,336,647 $ 490,107 $ 543,854 $ Change in Control with No Termination Annual incentive compensation payment (a)(f) 2,041,680 $ 758,824 $ 695,673 $ 280,839 $ 272,581 $ Acclerated vesting of stock option and restricted stock awards (e) 4,708,211 1,934,921 2,025,168 800,798 942,723 Distribution of LTIP awards (k) 1,810,090 930,766 1,036,052 517,512 465,383 280G Gross-up payment (g) - - - - - Total 8,559,981 $ 3,624,511 $ 3,756,893 $ 1,599,149 $ 1,680,687 $ Qualifying Termination following or in connection with a Change in Control Severence payment (a)(h) 8,648,790 $ 3,606,672 $ 3,918,519 $ 1,187,678 $ 982,162 $ Annual incentive compensation payment (a)(f) 2,041,680 758,824 695,673 280,839 272,581 Welfare benefit continuation and perquisite continuation and outplacement assistance (i) 597,757 218,923 97,900 194,220 62,536 Company contribution to deferred compensaton plans (j) 1,248,138 503,220 612,462 199,530 130,114 Acclerated vesting of stock option and restricted stock awards (e) 4,708,211 1,934,921 2,025,168 800,798 942,723 Distribution of LTIP awards (k) 1,810,090 930,766 1,036,052 517,512 465,383 280G Gross-up payment (g) 3,408,362 1,303,285 1,642,602 - - Total 22,463,028 $ 9,256,611 $ 10,028,376 $ 3,180,577 $ 2,855,499 $ CHEMED CORPORATION SUMMARY OF PAYOUTS UNDER CONTRACT/SEVERANCE/CONTROL AGREEMENTS As of December 31, 2012

35

 
 
(a)	The amounts shown are based on the following base salaries as of December 31, 2012 and average annual incentive compensation for the 2010, 2011 and 2012 fiscal years: for Mr. McNamara, $841,250 base salary and $2,041,680 annual incentive compensation; for Mr. Williams, $443,400 base salary and $758,824 annual incentive compensation; for Mr. O’Toole, $610,500 base salary and $695,673 annual incentive compensation; for Mr. Lee, $313,000 base salary and $280,839 annual incentive compensation; and for Mr. Tucker, $218,500 base salary and $272,581 annual incentive compensation.	
(b)	The severance payment is a lump-sum payment equal to: for Mr. McNamara, five times his base salary; for each of Messrs. Williams and O’Toole, two and a half times his base salary; and for each of Messrs. Lee and Tucker, one and a half times his base salary.	
(c)	The amounts shown consist of, for the period specified in the employment agreements of Messrs. McNamara, Williams and O’Toole, or, for Messrs. Lee and Tucker, in the Senior Executive Severance Policy, the continued provision of welfare benefits under the Company’s welfare benefit plans. With respect to these benefits, the amounts shown have been calculated based upon the current premiums paid by the Company for such benefits.	
(d)	Upon termination without cause or due to death or disability, the restricted stock awards held by each named executive officer will vest in full.  Upon termination due to retirement, the restrictions will lapse as to a fraction of the restricted stock equal to the length of time, in years, from the date granted to the date of retirement over the total number of years over which the award would have vested. The value of each share of restricted stock subject to acceleration was determined by multiplying the number of such restricted shares by $68.59 (the closing price of one share of Capital Stock on December 31, 2012).	
(e)	The value of each stock option award subject to acceleration was determined by multiplying the number of stock option awards by the excess, if any, of $68.59 (the closing price of one share of Capital Stock on December 31, 2012) over the exercise price of such stock option awards.  The value of each share of restricted stock subject to acceleration was determined by multiplying the number of such restricted shares by $68.59 (the closing price of one share of Capital Stock on December 31, 2012).	
(f)	The incentive payment is equal to the executive’s average annual incentive compensation for the 2010, 2011 and 2012 fiscal years.	
(g)	The amount of the excise taxes imposed pursuant to Section 4999 of the Code was determined by multiplying by 20% the “excess parachute payment” that would arise in connection with payments made to the applicable named executive officer upon the triggering event.  The excess parachute payment was determined in accordance with the provisions of Section 280G of the Code. The amount of the gross-up payment to make each named executive officer whole on an after-tax basis for the excise taxes imposed under Section 4999 of the Code was determined assuming a federal tax rate of 39.6% and 6% state tax rate for each named executive officer except for Mr. O’Toole, whose state tax rate is 0%.	
(h)	The severance payment is equal to: for each of Messrs. McNamara, Williams and O’Toole, three times the sum of his current base salary and average annual incentive compensation for the 2010, 2011 and 2012 fiscal years; for each of Messrs. Lee and Tucker, two times the sum of his current base salary and average annual incentive compensation for the 2010, 2011 and 2012 fiscal years.  For a description of the current base salary and average annual incentive compensation for 2010, 2011 and 2012 for each of the named executive officers, see footnote (a) to this table above.	
(i)	The amounts shown assume that Messrs. McNamara, Williams and O’Toole elect to receive their severance benefits under the Change in Control Plan, which will result in each receiving greater benefits than he would be entitled to receive under his employment agreement.  Accordingly, the amounts shown consist of, for the period specified in the Change in Control Plan, (i) the continued provision of the perquisites (if any) listed in the All Other Compensation Table at 2012 levels, (ii) the continued provision of benefits under the Company’s welfare benefit plans, and (iii) outplacement assistance. With respect to the continued provision of benefits under the Company’s welfare benefit plans, the amounts shown have been calculated based upon the current premiums paid by the Company for such benefits.	
(j)	The amounts shown equal the amount of Company contributions that would have been made on the executive’s behalf in the Company’s qualified and non-qualified defined contribution plans had the executive continued participation in such plans, at the level in effect on December 31, 2012, for a three-year period following a Qualifying Termination for Messrs. McNamara, Williams and O’Toole, and a two-year period following a Qualifying Termination for Messrs. Lee and Tucker.	
(k)	The amounts shown are the December 31, 2012 market value of the LTIP shares allocated on November 9, 2012.	

36

 
 
Termination Without Cause Prior to and Not in Connection With a Change in Control of the Company; Termination Due to Death, Disability or Retirement
 
Employment Agreements
 
The Company has entered into employment agreements with each of Messrs. McNamara, Williams and O’Toole.  Pursuant to the terms of these agreements, each would be entitled to cash severance benefits if his employment was terminated without cause or due to termination of his employment by reason of his death, disability or retirement.
 
For a termination without cause, Mr. McNamara would be entitled to a lump-sum payment equal to five times his then-current base salary plus a pro-rated portion of his average annual incentive compensation for the then-past three full fiscal years, and each of Messrs. Williams and O’Toole would be entitled to a lump-sum payment equal to two and a half times his then-current base salary plus a pro-rated portion of his average annual incentive compensation for the then-past three full fiscal years.  Mr. McNamara would also be entitled to continue to participate in the Company’s welfare benefit plans for 24 months following termination at the then-current rate of contribution.  Each of Messrs. Williams and O’Toole would be entitled to continue to participate in the Company’s welfare benefit plans for 18 months following termination at the then-current rate of contribution.  Such severance payments and benefits are conditioned upon execution of a general release of claims in favor of the Company, nondisclosure and, for Mr. McNamara, two-year non-compete and non-solicitation covenants and, for Messrs.  Williams and O’Toole, one-year non-compete and non-solicitation covenants.
 
The definition of “cause” pursuant to the employment agreements is (a) the willful and repeated failure of the executive to substantially perform his duties, other than a failure resulting from physical or mental illness; (b) the executive’s conviction of, or plea of guilty or nolo contendere to, a felony which is materially and demonstrably injurious to the Company; or (c) the executive’s engagement in willful gross misconduct or gross negligence in connection with his employment.
 
For a termination due to death, disability or retirement, each of Messrs. McNamara, Williams and O’Toole would be entitled to a lump-sum payment equal to the pro-rated portion of the average of his annual incentive compensation for the then-past three full fiscal years.  Such severance payments under each employment agreement for a termination due to disability or retirement are conditioned upon execution of a general release of claims in favor of the Company and a nondisclosure covenant.
 
If the payments set forth above were subject to the excise taxes imposed by Section 409A of the Code, Messrs. McNamara, Williams and O’Toole would be entitled to a gross-up payment. For purposes of the quantification of possible payments due to Messrs. McNamara, Williams and O’Toole in each of the scenarios set forth in the table above, it is assumed that no excise taxes pursuant to Section 409A of the Code would be imposed.  As such, the amounts in the table under the heading “Qualifying Termination following or in connection with a Change in Control” do not reflect a gross-up payment with respect to any excise tax pursuant to Section 409A of the Code.
 
Senior Executive Severance Policy
 
The Senior Executive Severance Policy, described in more detail in the Compensation Discussion and Analysis above, provides cash severance benefits to participants upon a termination without cause or due to death, disability or retirement.  The Senior Executive Severance Policy covers 13 employees, including Messrs. Lee and Tucker.  Messrs. McNamara, Williams and O’Toole are not covered by this policy.
 
For a termination without cause, each of Messrs. Lee and Tucker would be entitled to a lump-sum payment equal to one and a half times his then-current base salary plus a pro-rated portion of his average annual incentive compensation for the then-past three full fiscal years.  Messrs. Lee and Tucker would also be entitled to continue to participate in the Company’s welfare benefit plans for one year following termination of employment at the then-current rate of contribution.  The definition of “cause” under the Senior Executive Severance Policy is identical to the definition of cause under the employment agreements described above.

37

 
 
For a termination due to death, disability or retirement, each of Messrs. Lee and Tucker would be entitled to a lump-sum payment equal to the pro-rated portion of the average of his annual incentive compensation for the then-past three full fiscal years.
 
If the payments set forth above were subject to the excise taxes imposed by Section 409A of the Code,  Messrs. Lee and Tucker would be entitled to a gross-up payment.  For purposes of the quantification of possible payments due to Messrs. Lee and Tucker upon termination under the Senior Executive Severance Policy in each of the scenarios set forth in the table above, it is assumed that no excise taxes pursuant to Section 409A of the Code would be imposed.   As such, the amounts in the table under the heading “Potential Payment to Executives Upon Termination or Change in Control” do not reflect a gross-up payment with respect to any excise tax pursuant to Section 409A of the Code.
 
Severance payments and benefits under the Senior Executive Severance Policy are conditioned upon execution of a general release of claims in favor of the Company.  Additionally, for a termination without cause or due to disability or retirement, such severance payments and benefits are conditioned upon nondisclosure and one-year non-compete and non-solicitation covenants.
 
Equity Compensation Plans
 
Pursuant to the Stock Incentive Plans, all restricted stock awards vest upon the holder’s termination of employment due to death, disability or termination without cause.  Upon the holder’s retirement, the restrictions will lapse as to a fraction of the restricted stock equal to the length of time, in years, from the date such awards were granted to the date of the holder’s retirement over the total number of years over which the award would have vested.  Vested stock option awards granted under the Stock Incentive Plans remain exercisable for three months following termination of the holder’s employment, if the Compensation Committee so specifically consents, except for termination due to death, incapacity or retirement, in which case vested stock option awards remain exercisable for 15 months following termination and unvested options continue to vest for 3 months upon retirement.  Unvested stock option awards are forfeited upon termination of employment for any reason.  For a description of the treatment of outstanding unvested stock option awards and restricted stock awards upon a change in control of the Company, see the narrative under the heading “Potential Payment to Executives Upon Termination or Change in Control -- Change in Control of the Company” below.
 
Change in Control of the Company
 
Change in Control Plan
 
The Change in Control Plan, described in additional detail in the Compensation Discussion and Analysis, covers 16 executive officers of the Company, including the named executive officers.  However, in the event of a change in control of the Company, Messrs. McNamara, Williams and O’Toole would not receive benefits under both their employment agreements and the Change in Control Plan, and the participants in the Senior Executive Severance Policy would not receive benefits under both the Senior Executive Severance Policy and the Change in Control Plan.
 
Under the Change in Control Plan, a change in control of the Company means, in general, the occurrence of any one of the following events: (a) certain acquisitions by a third party of at least 30% of the then-outstanding Capital Stock; (b) individuals who constituted the Board of Directors when the plan became effective (the “Incumbent Board”) cease to constitute at least a majority of the Board (provided that the Incumbent Board will be deemed to include any director (other than one elected in certain contested solicitations) whose election, or nomination by the stockholders for election, to the Board was approved by a majority of the Board members then comprising the Incumbent Board); (c) consummation of certain mergers, consolidations and similar transactions involving the Company unless the Company is the surviving entity and no person holds 30% or more of the then-outstanding Capital Stock (except to the extent such ownership existed prior to the transaction) and individuals who were members of the Incumbent Board constitute at least a majority of the Board following such transaction; (d) approval by the Company’s stockholders of a plan for the complete liquidation or dissolution of the Company or the sale of all or substantially all of the Company’s assets; or (e) any other transaction that the Compensation Committee or such other committee as determined by the Board deems to be a change in control.

38

 
 
The Change in Control Plan provides for severance payments and benefits in the event of a change in control of the Company followed within two years by an executive’s termination of employment either without cause or for good reason (“double trigger”).  Payments under the Change in Control Plan are triggered by (a) termination of employment by the Company without cause or (b) termination of employment by the employee within 90 days of an event giving him or her good reason to so terminate (such termination without cause or for good reason, a “Qualifying Termination”).  The definition of cause is identical to the definition of cause in the employment agreements discussed above.  Good reason consists of a   material reduction in the nature and scope of the participant’s responsibilities, authority or duties; a reduction in the participant’s base salary below the participant’s highest base salary during the 120-day period prior to or any time following a change in control, annual incentive compensation below the participant’s average annual incentive compensation for the then-past three full fiscal years prior to the change in control, equity-based compensation below that received during the 120-day period prior to the change in control or in the aggregate level of employee benefits; a relocation of the participant’s principal work location by more than 50 miles; or notice of the Company’s intention to cancel or not renew his employment agreement.
 
Upon a Qualifying Termination, Messrs. McNamara, Williams and O’Toole would receive a payment equal to three times, and Messrs. Lee and Tucker would receive a payment equal to two times, the sum of (a) such named executive officer’s highest base salary during the 120-day period prior to or any time following the change in control and (b) the average of such named executive officer’s annual incentive compensation for the then-past three full fiscal years prior to the change in control, all paid in cash in a lump-sum within 10 days following termination.  If the Qualifying Termination were to take place in a fiscal year other than the fiscal year during which the change in control occurred, each named executive officer would also receive a pro-rated portion of his three-year average annual incentive compensation.
 
Upon a Qualifying Termination, participants would also be entitled to receive benefits under the Company’s welfare benefit plans and perquisites for a period of three years (for Messrs. McNamara, Williams and O’Toole) or two years (for Messrs. Lee and Tucker), and outplacement assistance up to $25,000.  Such perquisites would be provided at a level comparable to the level of perquisites received immediately prior to the Qualifying Termination or the change in control, whichever would be more favorable to the participant.  If the employee becomes re-employed during the applicable two-year or three-year period and is eligible to receive   comparable benefits from his new employer, the benefits provided by the Company under its welfare benefit plans are secondary to those provided by the new   employer.
 
Within 10 days of a Qualifying Termination, a participant would also be entitled to receive a lump-sum cash payment in the amount of employer contributions to the participant’s account in the Company’s qualified and non-qualified defined contribution plans, assuming the participant’s participation in the plans had continued on the same basis as immediately prior to the termination for the applicable three-year period (for Messrs. McNamara, Williams and O’Toole) or two-year period (for Messrs. Lee and Tucker).
 
Regardless of whether a participant is terminated and in addition to the severance benefits set forth above, upon a change in control, each participant in the Change in Control Plan would receive, within 10 days following the change in control, a lump-sum payment equal to the average of the participant’s annual incentive compensation for the then-past three full fiscal years, and all unvested portions of stock option and restricted stock awards would vest in full upon the date of the change in control.  In addition, the Change in Control Plan provides that the Compensation Committee would distribute any shares of Capital Stock as of the date of the change in control under the Company’s equity-based plans to the participants of such equity-based plans upon the change in control.  The payments described in this paragraph are referred to as “single-trigger” payments.
 
All payments under the Change in Control Plan are conditioned on execution of a general release of claims in favor of the Company.  If payments under the Change in Control Plan were subject to taxes imposed by Sections 4999 or 409A of the Code, the participant would be entitled to a gross-up payment.  For purposes of the quantification of possible payments due to the named executive officers pursuant to the Change in Control Plan, it is assumed that no excise tax pursuant to Section 409A of the Code would be imposed.  As such, the amounts in the table under the heading “Qualifying Termination following or in connection with a Change in Control” do not reflect a gross-up payment with respect to any excise taxes pursuant to Section 409A of the Code.   The amount of gross-up payments to which the named executive officers would be entitled with respect to tax imposed by Section 4999 of the Code are set forth in the table above under the heading “Potential Payment to Executives Upon Termination of Change in Control”, and the assumptions used in determining the amounts are set forth in footnote (g) of such table.

39

 
 
Equity Compensation Plans
 
Pursuant to the Stock Incentive Plans, upon a change in control of the Company, all outstanding unvested stock option and restricted stock awards would become fully vested.  Under the Stock Incentive Plans, a change in control of the Company means, in general, the occurrence of any one of the following events: (a) certain acquisitions by a third party of at least 30% of the then-outstanding Capital Stock; (b) the expiration of a tender offer or exchange offer (other than an offer by the Company) pursuant to which 20% or more of the shares of Capital Stock have been purchased; (c) merger or consolidation in which the Company is not the surviving corporation, a plan for the liquidation of the Company or an agreement for the sale or other disposition of all or substantially all of the Company’s assets; or (d) during any period of two consecutive years, individuals who constitute the Board of Directors at the beginning of such period cease to constitute at least a majority of the Board (provided that the Board at the beginning of such period shall be deemed to include any director whose nomination for election was approved by at least one-half of the persons who were directors (or deemed to be directors) at the beginning of the two-year period).

Deferred Compensation Plans
 
Upon a termination for any reason, each of Messrs. McNamara, Williams, O’Toole and Tucker would be entitled to the aggregate balance in his account in the Excess Benefit Plan, and Mr. Lee would be entitled to the aggregate balance in his account in the Deferred Compensation Plan.  Each of the named executive officers would also be entitled to the aggregate balance in his account in the Supplemental Pension Plan, and Mr. Tucker would be entitled to the aggregate balance in his account in the 1986 Severance Plan. The aggregate balances in these accounts for each named executive officer are set forth in the Non-Qualified Deferred Compensation Table above.

CERTAIN RELATIONSHIPS AND TRANSACTIONS
 
Mr. Gemunder is a director of the Company and until his retirement in August 2010 was a director and President and Chief Executive Officer of Omnicare.  Until May of 2010, Ms. Laney, a director emeritus of the Company, was also a director of Omnicare.  Ms. Lindell is a director of the Company and Omnicare.
 
Ms. Laney receives $15,000 per year as chairperson of the Chemed Foundation, a charitable organization affiliated with the Company.
 
In October 2004, a subsidiary of Vitas Healthcare Corporation (“Vitas”) entered into a pharmacy services agreement with Omnicare, pursuant to which Omnicare provides specified pharmacy services for Vitas and its hospice patients in geographical areas served by both Vitas and Omnicare.  The agreement had an initial term of three years and renews automatically thereafter for one-year terms.  Either party may cancel the agreement at the end of any term by giving written notice at least 90 days prior to the end of the term.  In June 2004, Vitas entered into a pharmacy services agreement with excelleRx.  The agreement had an initial term of one year and automatically renews unless either party provides a 90-day written notice of non-renewal.  After June 2004, Omnicare acquired excelleRx.  During 2012, Vitas made purchases of $40.9 million from Omnicare under these two agreements.
 
In connection with the August 2001 sale of assets of the Company’s former subsidiary, Cadre Computer Resources, Inc., to Cadre Computer Resources Co. (“Cadre Computer”), Cadre Computer subleased 7,800 square feet of office space from the Company at a rate of $17.81 per square foot plus operating costs until September 2012 when the lease terminated.  Messrs. McNamara and Williams and Ms. Laney serve as directors of Cadre Computer.  Ms. Laney, who is chairman and Chief Executive Officer of Cadre Computer, also has a majority ownership interest in Cadre Computer.

40

 
 
SECURITY OWNERSHIP OF CERTAIN
BENEFICIAL OWNERS AND MANAGEMENT
 
This table sets forth information as of December 31, 2012, with respect to the only persons known to us to beneficially own more than 5% of the outstanding Capital Stock:

 	Name or Address
Of Beneficial Owner	Amount and Nature of
Beneficial Ownership	Percent of Class (a)	
 	FMR, LLC
82 Devonshire Street
Boston, MA 02109
 
Royce & Associates, LLC
745 Fifth Avenue
New York, New York 10151
 
BlackRock, Inc.
40 E. 52nd Street
New York, NY 10022
 
Vanguard Group, Inc.
100 Vanguard Boulevard
Malvern, PA 19355
 
Riverbridge Partners LLC
Suite 600
801 Nicolett Mall
Minneapolis, MN 55402
 	2,351,527 shares (b)

 
1,823,098 shares (d)

 
1,400,442 shares (f)

 
1,257,083 shares (h)

 
1,211,809 shares (j)	12.19% (c)

 
9.45% (e)

 
7.26% (g)

 
6.51% (i)

 
6.28% (k)	

(a) For purposes of calculating Percent of Class, all shares of Capital Stock subject to stock option awards which were exercisable within 60 days of December 31, 2012, were assumed to have been issued.
(b) Sole voting power, 52,408 shares; sole dispositive power, 2,351,527 shares.
(c) Information is based on Schedule 13GA filed with the SEC on February 13, 2013.
(d) Sole voting power, 1,823,098 shares; sole dispositive power, 1,823,098 shares.
(e) Information is based on Schedule 13G filed with the SEC on January 7, 2013.
(f) Sole voting power 1,400,442 shares, sole dispositive power 1,400,442 shares.
(g) Information is based on a Schedule 13G filed with the SEC on February 4, 2013.
(h) Sole voting power 26,857 shares; shared voting power, none; sole dispositive power 1,231,126 shares; shared dispositive power 25,957 shares.
(i) Information is based on a Schedule 13G filed with the SEC on February 7, 2013.
(j) Sole voting power 942,726 shares, sole dispositive power 1,211,809 shares.
(k) Information is based on a Schedule 13G filed with the SEC on February 4, 2013.

41

 

This table shows the shares of Capital Stock beneficially owned and pledged, if any, by all nominees and directors of the Company, the executive officers named in the Summary Compensation Table and the Company’s directors and executive officers as a group as of December 31, 2012:

 
(a)	Such securities include shares of Capital Stock allocated as of December 31, 2012, to the account of each named person or member of the group under the Retirement Plan or, with respect to Mr. Gemunder, allocated to his account as of December 31, 2012, under the Omnicare Employees’ Savings and Investment Plan (the “Omnicare Savings Plan”).  “Option” refers to shares of Capital Stock which the named person or group has a right to acquire within 60 days from December 31, 2012.  Except as otherwise disclosed in this Proxy Statement, each director, director nominee and executive officer has sole voting and investment power over the shares of Capital Stock shown as beneficially owned.  No such shares are pledged.	
(b)	Mr. T. C. Hutton is a trustee of several trusts and private foundations which hold in the aggregate, 35,467 shares over which the trustee has shared voting and investment power.  Messrs.  McNamara and T. C. Hutton and Ms. Laney are trustees of the Chemed Foundation, which holds 108,876 shares of Capital Stock over which the trustees share both voting and investment power.  This number is included in the total number of “Trustee” shares held by the Directors and Executive Officers as a Group but is not reflected in the respective holdings of the individual trustees.	
(c) 	Percent of Class includes Direct, Option and Trustee shares where indicated.  For purposes of determining the Percent of Class, all shares of Capital Stock subject to stock option awards which were exercisable within 60 days from December 31, 2012, were assumed to have been issued.  Percent of Class under 1.0% is not shown.  Shares of Capital Stock over which more than one individual holds beneficial ownership have been counted only once in calculating the aggregate number of shares of Capital Stock owned by Directors and Executive Officers as a Group.	

42

 
 
Section 16(a) Beneficial Ownership Reporting Compliance
 
During 2012, all reports for the Company’s executive officers, directors and beneficial owners of more than 10% of the outstanding shares of Capital Stock required to be filed under Section 16(a) of the Securities Exchange Act of 1934 were filed on a timely basis.
 
Anti-Hedging Policy
 
The Company does not permit its officers or directors to indirectly or directly hedge any shares of Capital Stock.
 
RATIFICATION OF SELECTION OF INDEPENDENT REGISTERED PUBLIC ACCOUNTANTS
 
The Audit Committee has selected the firm of PricewaterhouseCoopers LLP as independent accountants for the Company and its consolidated subsidiaries for 2013.  This firm has acted as independent accountants for the Company and its consolidated subsidiaries since 1970.  Although the submission of this matter to the stockholders is not required by law or by the bylaws of the Company, the selection of PricewaterhouseCoopers LLP will be submitted for ratification at the Annual Meeting.  The affirmative vote of the majority of the shares represented at the meeting, with abstentions having the effect of negative votes, will be necessary to ratify the selection of PricewaterhouseCoopers LLP as independent accountants for the Company and its consolidated subsidiaries for 2013.  Representatives of PricewaterhouseCoopers LLP are expected to be present at the Annual Meeting, will have the opportunity to make a statement if they so desire and are expected to be available to respond to appropriate questions.  The Board unanimously recommends that you vote FOR the ratification of the Audit Committee’s selection of independent accountants.   If the selection is not ratified at the meeting, the Audit Committee will reconsider its selection of independent accountants.
 
AUDIT COMMITTEE REPORT
 
The Audit Committee is appointed by the Board of Directors to assist the Board in monitoring:
 
·  	The integrity of the Company’s financial statements.	
 
·  	Compliance by the Company with legal and regulatory requirements.	
 
·  	The independence and performance of the Company’s internal and external auditors.	
 
During 2000, the Audit Committee developed a charter for the Committee, which was approved by the full Board of Directors on May 15, 2000.  The charter was most recently amended on November 10, 2006.  A copy of the charter is available on the Company’s Web site, www.chemed.com.
 
The Company’s management has primary responsibility for preparing the Company’s financial statements and for the Company’s financial reporting process.  The Company’s independent accountants, PricewaterhouseCoopers LLP, are responsible for expressing an opinion on the conformity of the Company’s audited financial statements to generally accepted accounting principles.

43

 
 
In this context, the Audit Committee hereby reports as follows:
 
1.	The Audit Committee has reviewed and discussed the audited financial statements and management’s report on internal control over financial reporting with the Company’s management.	
 
2.	The Audit Committee has discussed with the independent accountants the matters required to be discussed by SAS 61, as amended (Codification of Statements on Auditing Standard, AU 380), as adopted by the Public Company Accounting Oversight Board in Rule 3200T.	
 
3.	The Audit Committee has received the written disclosures and the letter from the independent accountants required by the applicable requirements of the Public Company Accounting Oversight Board regarding the independent accountants’ communications with the Audit Committee concerning independence and has discussed with the independent accountants the independent accountants’ independence.	
 
4.	Based on the review and discussion referred to in paragraphs (1) through (3) above, the Audit Committee recommended to the Board of Directors that the audited financial statements be included in the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2012, for filing with the SEC.	
 
Each of the members of the Audit Committee is independent as defined under the listing standards of the New York Stock Exchange.
 
The undersigned members of the Audit Committee have submitted this Report.
 
Donald E. Saunders, Chairman
Patrick P. Grace
Thomas P. Rice

FEES PAID TO INDEPENDENT REGISTERED PUBLIC ACCOUNTANTS
 
Audit Fees
 
PricewaterhouseCoopers LLP billed the Company $1,610,000 for 2011 and $1,680,000 for 2012.  The fees and related expenses were for professional services rendered for the integrated audit of the Company’s annual financial statements and of its internal controls over financial reporting, review of the financial statements included in the Company’s Forms 10-Q and review of documents filed with the SEC.
 
Audit-Related Fees
 
PricewaterhouseCoopers LLP billed the Company $127,000 and $129,000 for 2011 and 2012, respectively, for audit-related services.  These services were related to the audit of one of Vitas’ Florida subsidiaries.
 
Tax Fees
 
No such services were rendered during 2011 or 2012.
 
All Other Fees
 
No such services were rendered during 2011 or 2012.
 
The Audit Committee has adopted a policy which requires the Committee’s pre-approval of audit and non-audit services performed by the independent auditor to assure that the provision of such services does not impair the auditor’s independence.  The Audit Committee pre-approved all of the audit and non-audit services rendered by PricewaterhouseCoopers LLP as listed above.

44

 
 
ADVISORY VOTE TO APPROVE EXECUTIVE COMPENSATION
 
The Board is submitting this Say On Pay proposal pursuant to Section 14A of the Securities Exchange Act of 1934, which allows our stockholders to cast a non-binding vote to approve the compensation of our named executive officers as disclosed in the Compensation Discussion and Analysis and accompanying compensation tables in this Proxy Statement.
 
In deciding how to vote on this proposal, the Board urges you to carefully consider the actions taken and the major changes related to the Company’s executive compensation practices made in response to last year’s advisory vote, more fully described in the Compensation Discussion and Analysis beginning on page 14.  We encourage stockholders to review the Compensation Disclosure and Analysis above.  Our creation of value over time is due to the efforts of our talented and committed executives.  As discussed above in Compensation Discussion and Analysis, the Board believes that our current executive compensation program directly links executive compensation to our financial performance and aligns the interests of our executive officers with those of our stockholders.  Our Board also believes that our executive compensation program provides our executive officers with a balanced compensation package that includes a reasonable base salary along with annual and long-term incentive compensation plans that are based on the Company’s financial performance.  For 2012, about 73 percent of our President and Chief Executive Officer’s actual total direct compensation was performance-based, while the average for the other named executive officers was about 64 percent.  “Performance-based” compensation includes non-equity incentive awards, option awards, and equity incentive and market-based stock awards.  These incentive plans are designed to reward our executive officers on both an annual and long-term basis if they attain specified target goals, the attainment of which do not require the taking of an unreasonable amount of risk, as discussed above in Compensation Risk Assessment.   Our stockholders did not vote in favor of executive compensation in 2012 as discussed above in Consideration of the 2012 Say On Pay Vote .   We believe this was caused in part by a short-term decline in our stock price beginning in mid-November 2011 that ended in mid-January 2012.  This decline in total stockholder return proved temporary.
 
As a result of the negative vote, the Compensation Committee recommended changes to our executive compensation program, which were approved by the Board, as described above.  We believe our executive compensation program is intended to achieve the objective of aligning executives’ interests with those of stockholders.  It rewards executives for long-term growth in the value of Capital Stock through encouraging them to hold a significant amount of the Company’s equity; paying for performance through both cash and equity-based incentives that, in turn, provide greater rewards for stronger performance of the Company as a whole and the Company’s business units; paying competitively in order to attract and retain senior executives; and creating incentives to maximize the long-term growth of the Company’s business.  The weighting of incentive compensation toward long-term awards discourages short term risk taking.  Rolling performance targets also discourage such behavior.  Further, the Company’s Stock Ownership Guidelines discourage such behavior by aligning employees’ interests with those of stockholders.
 
The elements of the Company’s compensation program include base salary, annual cash incentive compensation and long-term incentive compensation in the forms of stock option awards, restricted stock awards and awards under the LTIP (in the form of cash and restricted and fully vested stock awards).  Each salary, annual cash incentive compensation and pension and welfare benefits plan amount is established by the non-employee members of the Board of Directors based upon levels that the Compensation Committee and such Board members determine are competitive and are intended to reward for current and past performance, while longer-term incentives such as stock option awards, restricted stock awards and awards under the LTIP, are intended to create incentive for future growth.  Restricted stock awards generally vest on the fourth anniversary of the date granted.
 
In 2011 stockholders voted to conduct an advisory vote on executive compensation every year.  The Board has adopted this frequency.
 
The Board endorses the Company’s executive compensation program and recommends stockholders vote in favor of the following resolution:
 
“RESOLVED, that compensation paid to the Company’s executive officers as disclosed pursuant to Item 402 of Regulation S-K described in this proxy statement under “Executive Compensation”, including the Compensation Discussion and Analysis, Compensation tables and narrative discussion contained in this proxy statement, is hereby APPROVED.”

45

 
 
Because the vote is advisory, it will not be binding upon the Board or the Compensation Committee and neither the Board nor the Compensation Committee will be required to take any action as a result of the outcome of the vote on this proposal.  The Compensation Committee will carefully consider the outcome of the vote when considering future executive compensation arrangements.
 
The Board of Directors unanimously recommends a vote FOR the approval of the Company’s executive compensation.
 
STOCKHOLDER PROPOSALS
 
Any stockholder proposals for the 2014 Annual Meeting of Stockholders must be in writing and received by the Secretary of the Company by December 6, 2013 to be eligible for inclusion in the Company’s proxy statement and accompanying proxy for such meeting, unless the date of the 2014 Annual Meeting of Stockholders is changed by more than 30 days from May 20, 2014, in which case such proposal must be received a reasonable time before the Company begins to print and send its proxy materials for such meeting.  If a stockholder intends to bring a matter before the 2014 Annual Meeting of Stockholders other than by submitting a proposal for inclusion in the Company’s proxy materials for such meeting he or she must provide notice of the proposal to the Company’s secretary at our principal executive offices no earlier than January 20, 2014 and not later than February 19, 2014 for such notice to be considered timely.  If the date of the 2014 meeting is advanced by more than 30 days, or delayed by more than 90 days from May 20, 2014, such proposal must be received not earlier than the close of business on the 120 th  day prior to such Annual Meeting and not later than the close of business on the later of the 90 th  day prior to such meeting, or, if the first public announcement of such meeting is less than 100 days prior to it, the 10 th  day following the day the Company made such public announcement.  In the case of untimely notice of a proposal, persons named in the proxies solicited by the Company for the 2014 Annual Meeting of Stockholders (or their substitutes) will be allowed to use their discretionary voting authority when the proposal is raised at the meeting without any discussion of the proposal in its proxy materials.
 
IMPORTANT NOTICE REGARDING THE AVAILABILITY OF PROXY MATERIALS
FOR THE ANNUAL MEETING
 
The Proxy Statement and the Company’s 2012 Annual Report are available on the Company’s Web site at   http://www.chemed.com.
 
Information on how to obtain directions to be able to attend the meeting and vote in person are available by contacting:

Wells Fargo Shareowner Services
1-800-468-9716

—or—

You may write to us at:
 
Chemed Corporation
Investor Relations
Suite 2600
255 East Fifth Street
Cincinnati, Ohio  45202-4726

The Company makes available, free of charge on its Web site, the Proxy Statement, Annual Report on Form 10-K, Quarterly Reports on Form 10-Q, Current Reports on Form 8-K and amendments to these reports filed or furnished pursuant to Section 13(a) or 15(d) of the Exchange Act, as soon as reasonably practicable after these documents are electronically filed with, or furnished to, the SEC.  These documents are posted on the Web site at   www.chemed.com. Select the “SEC Filings” link.

46

 

A copy of the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2012 filed with the SEC (without exhibits) will also be made available to stockholders without charge upon written request to Chemed Investor Relations, Suite 2600, 255 East Fifth Street, Cincinnati, Ohio 45202 - 4726.

DUPLICATE
 
ANNUAL REPORT AND PROXY STATEMENT
 
If you are a stockholder of record and share an address with another stockholder and have received only one copy of the Company’s 2012 Annual Report or Proxy Statement, the Company undertakes to promptly deliver upon written or oral request a separate copy of these materials at no cost to you.  In addition, if you are a stockholder of record and share an address with another stockholder and have received multiple copies of the Company’s 2012 Annual Report or Proxy Statement, you may write or call the Company to request delivery of a single copy of such materials in the future.  You may write to the Company at Suite 2600, 255 East Fifth Street, Cincinnati, Ohio 45202-4726, Attn: Investor Relations, or call 1-800-2CHEMED or 1-800-224-3633.
 
OTHER MATTERS
 
As of the date of this Proxy Statement, management has not been notified of any stockholder proposals intended to be raised at the Annual Meeting outside of the Company’s proxy solicitation process nor does it know of any other matters which will be presented for consideration at the Annual Meeting.  However, if any other stockholder proposals or other business should come before the Annual Meeting, the persons named in the enclosed proxy (or their substitutes) will have discretionary authority to take such action as is in accordance with their best judgment.
 
MISCELLANEOUS

The Company will pay all solicitation expenses in connection with this Proxy Statement and related Company proxy soliciting material, including the expense of preparing, printing, assembling and mailing this Proxy Statement and any other material used in the Company’s solicitation of proxies.  Proxies are being solicited through the mail. Certain executive officers and other employees of the Company, on behalf of the Company and without additional compensation, may also solicit proxies personally, by telephone, fax, email or other electronic means.

The Company will request banks, brokers and other custodians, nominees and fiduciaries to forward proxy soliciting material to the beneficial owners of shares held of record by such persons and obtain their voting instructions.  The Company will reimburse such persons at approved rates for their expenses in connection with the foregoing activities.

 
 	Naomi C. Dallob	
 	Secretary	

April 5, 2013

47